Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Articles

Page Path
HOME > Cancer Res Treat > Volume 51(2); 2019 > Article
Special Article Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016
Kyu-Won Jung, MS1,2, Young-Joo Won, PhD1,2,3,, Hyun-Joo Kong, MS1,2, Eun Sook Lee, MD, PhD1,4, The Community of Population-Based Regional Cancer Registries,*
Cancer Research and Treatment : Official Journal of Korean Cancer Association 2019;51(2):417-430.
DOI: https://doi.org/10.4143/crt.2019.138
Published online: March 18, 2019

1The Korea Central Cancer Registry, National Cancer Center, Goyang, Korea

2National Cancer Control Institute, National Cancer Center, Goyang, Korea

3Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea

4Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Korea

Correspondence: Young-Joo Won, PhD The Korea Central Cancer Registry, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang 10408, Korea
Tel: 82-31-920-2015 Fax: 82-31-920-2179 E-mail: astra67@ncc.re.kr
*The members of the group are listed at the end of this article.
• Received: March 12, 2019   • Accepted: March 13, 2019

Copyright © 2019 by the Korean Cancer Association

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 26,234 Views
  • 1,058 Download
  • 277 Web of Science
  • 288 Crossref
  • 295 Scopus
prev next
  • Purpose
    This study presents the 2016 nationwide cancer statistics in Korea, including cancer incidence, survival, prevalence, and mortality.
  • Materials and Methods
    Cancer incidence data from 1999 to 2016 were obtained from the Korea National Cancer Incidence Database and followed until December 31, 2017. Mortality data from 1983 to 2016 were obtained from Statistics Korea. The prevalence was defined as the number of cancer patients alive on January 1, 2017 among all cancer patients diagnosed since 1999. Crude and age-standardized rates (ASRs) for incidence, mortality, and prevalence and 5-year relative survivals were also calculated.
  • Results
    Overall, 229,180 and 78,194 Koreans were newly diagnosed and died from cancer in 2016, respectively. The ASRs for cancer incidence and mortality in 2016 were 269.0 and 79.8 per 100,000 individuals, respectively. The all-cancer incidence rate increased significantly by 3.6% annually from 1999 to 2011 and started to decrease after 2011 (2011-2016; annual percent change, –3.1%). However, overall cancer mortality has decreased 2.7% annually since 2002. The 5-year relative survival rate for patients diagnosed with cancer between 2012 and 2016 was 70.6%, an improvement from the 41.2% for patients diagnosed between 1993 and 1995.
  • Conclusion
    The cancer prevalence in Korea has increased very fast as survival has improved remarkably. The high prevalence of cancer emphasizes the need for comprehensive cancer control efforts in Korea.
The global cancer burden has risen to 18.1 million cases and 9.6 million cancer deaths in 2018 [1]. Cancer incidence and mortality are rapidly growing worldwide. The reasons are complex but reflect both aging and growth of the population, as well as changes in the prevalence and distribution of the main risk factors for cancer [2].
In Korea, cancer accounts for one in four deaths and more than 200,000 new cancer cases were diagnosed in 2015 [3]. The number of cancer incidences and deaths are expected to increase with an aging population and westernized lifestyles [4].
In this context, cancer statistics are the most important indicator to assess the national cancer burden, which can be used to establish cancer control strategies. This article aimed to provide nationwide cancer statistics including incidence, survival, prevalence, and mortality in 2016.
1. Data sources
The Korea Central Cancer Registry (KCCR) was established by the Ministry of Health and Welfare in 1980 as a nationwide hospital-based cancer registry. Since 1999, the KCCR has collected cancer incidence data nationwide by integrating a nationwide hospital-based KCCR database with data from regional cancer registries. The KCCR currently provides the nationwide cancer incidence, survival, and prevalence statistics annually [5].
The KCCR built the Korea National Cancer Incidence Database (KNCI DB) from hospitals, 11 population-based registries, and additional medical record reviews. The KNCI DB contains information regarding age, sex, region, date of diagnosis, primary cancer site, histological type, most valid diagnostic method, summary stage of surveillance, epidemiology and end results program (SEER) and first course of treatment within four months after diagnosis. The completeness of cancer incidence data for 2016 was estimated to be 98.2% based on the method proposed by Ajiki et al. [6]. The mid-year population and cancer mortality data from 1983 to 2016 were obtained from Statistics Korea [7]. To ascertain vital status and to calculate survival and prevalence, the KNCI DB was linked to mortality data and population registration data from the Ministry of the Interior.
2. Classification
All incidence cases were registered according to the International Classification of Diseases for Oncology, third edition [8] and converted to the International Classification of Diseases, 10th edition (ICD-10) [9]. The mortality cases were registered according to ICD-10. All cancer cases were reported based on the 24 cancer types.
3. Statistical analyses
Rates were expressed as crude and age-standardized rates (CR and ASR, respectively) per 100,000 individuals. The CR was calculated as the total number of incidence/mortality cases divided by the mid-year population of the specified years. The ASR is a weighted average of the age-specific rates, where the weights are the proportions of persons in the corresponding age groups of a standard population [10]. In this report, ASRs were calculated using Segi’s world standard population [11]. The cumulative risk of developing cancer from birth to life expectancy was calculated using cumulative rates; that is, the sum of the age-specific rates from birth to life expectancy, as follows [12]:
Cumulative risk of developing cancer from birth to life expectancy =100×1-e-cumulative rate100
Trends in ASRs were summarized as an annual percentage change (APC) by using a Joinpoint regression. APC is the average percentage change of ASRs and is calculated as follows [10]:
APC=Ry+1RyRy×100=eb1-1×100
, where log(Ry)=b0+b1y,
log(Ry) is the natural log transformed age standardized rates.
y=year, b0=intercept, b1=slope
The survival duration for each cancer case was determined as the interval between the date of initial diagnosis and the date of death, date of loss of follow-up, or closing date for follow-up, whichever came first. The 5-year relative survival rate was calculated as the ratios of the observed survival of the cancer patients to the expected survival of the general population, which was derived from the standard life table provided by Statistics Korea. Trends in 5-year relative survival rates were evaluated as percentage differences in 5-year relative survival rates from 1993-1995 and 2012-2016. Relative survival rates were calculated using the Ederer II method [13] with some minor corrections, based on an algorithm by Paul Dickman [14].
Prevalent cases were defined as the number of cancer patients alive on January 1, 2017 among all cancer patients diagnosed between 1999 and 2016. Limited-duration prevalences were calculated using SEER*Stat software. Any p-values less than 0.05 were considered statistically significant. SEER*Stat 8.1.2 (National Cancer Institute, Bethesda, MD), Joinpoint 4. 1. 1 (National Cancer Institute), and SAS ver. 9.4 (SAS Institute, Cary, NC) were used for statistical analysis.
1. Incidence
A total of 229,180 cancer cases were newly diagnosed in 2016, which included 120,068 men (52.4%) and 109,112 women (47.6%) (Table 1). Stomach cancer was the most commonly diagnosed cancer in 2016, followed by colorectal, thyroid, lung, and breast cancer. The overall cumulative risk of developing cancer from birth to life expectancy was 36.2%. The cumulative risk of developing cancer from birth to life expectancy was higher in men (38.3%) than in women (33.3%) (data not shown).
The total CR and ASR for overall cancer incidences in 2016 were 448.4 and 269.0 per 100,000, respectively (Table 2). According to sex, CRs for all sites combined were 470.3 per 100,000 in men and 426.5 per 100,000 in women. The ASRs were 298.0 and 254.6 per 100,000 in men and women, respectively. Stomach cancer (CR, 80.3 per 100,000) was the most common cancer in men, followed by lung (CR, 69.7 per 100,000), colorectal (CR, 65.3 per 100,000), prostate (CR, 46.2 per 100,000), and liver cancer (CR, 46.1 per 100,000). These five cancers accounted for 65.4% of newly diagnosed cases in men during the study period. In contrast, breast cancer (CR, 85.0 per 100,000) was the most common cancer among women, followed by thyroid (CR, 80.2 per 100,000), colorectal (CR, 44.8 per 100,000), stomach (CR, 39.1 per 100,000), and lung cancer (CR, 31.2 per 100,000). These five cancers accounted for 65.7% of cases in women.
2. Mortality
The total number of deaths from cancer in 2016 was 78,194, accounting for 27.8% of all deaths (Table 3). According to sex, 61.7% and 38.3% of cancer deaths occurred in men and women, respectively (Table 1).
The total CR and ASR for cancer deaths were 153.0 and 79.8 per 100,000, respectively, in 2016 (Table 4). The total CR and ASR for cancer deaths per 100,000 were higher among men (CR, 188.8; ASR, 115.5) than in women (CR, 117.2; ASR, 53.6).
According to the cancer sites, lung cancer (CR, 52.2 per 100,000) was the leading cause of death in men, followed by liver (CR, 31.5 per 100,000), stomach (CR, 20.8 per 100,000), colorectal (CR, 18.3 per 100,000), and pancreatic cancer (CR, 11.4 per 100,000). The top five causes of deaths from cancer in women included lung (CR, 18.1 per 100,000), colorectal (CR, 14.5 per 100,000), liver (CR, 11.6 per 100,000), stomach (CR, 11.5 per 100,000), and pancreatic cancer (CR, 10.6 per 100,000).
3. Trends in cancer incidence and mortality
Fig. 1 shows trends in cancer incidence and mortality from 1983 to 2016. The ASR for all-cancer incidence increased by 3.6% annually from 1999 to 2011, and then started to decrease from 2011 to 2016 (APC, –3.1%) (Table 5). Cases of stomach, colorectum, lung, and thyroid cancers started to decrease around 2011. Specifically, ASR for thyroid cancer increased rapidly to 22.6% from 1999 to 2011, but then decreased swiftly by 12.6% annually starting in 2011. The incidence of breast cancer increased constantly throughout the period; however, the APC slowed from 2005 onward. Conversely, the incidence rates of cervix and liver showed a constant decrease for the whole period. Thyroid cancer decreased the most drastically starting in the early 2010s (Fig. 2).
The ASR for all-cancer mortality rate increased until 2002 (Table 6). After that year, it started to decrease (2002-2016; APC, –2.7%). The same patterns were evident in men and women. Cancer incidence at most sites, including the cervix uteri, thyroid, liver, gallbladder, lung, brain and central nervous system, and colorectum started to decrease in the early 2000s. Furthermore, cancers of the lips, oral cavity and pharynx, esophagus, stomach, larynx, and non-Hodgkin lymphoma decreased from 1999. Breast cancer showed constant increasing trends for the whole period (Fig. 3).
4. Age-specific incidence rates
Leukemia was the most commonly diagnosed cancer among children between 0-14 years of age. Thyroid cancer was the most common cancer among adolescents and young adults between 15 and 34 years of age (Table 7). Stomach cancer was the most commonly diagnosed cancer among men aged 35 to 64 years, while lung cancer was the most common among men aged 65 years and above (Fig. 4A). In contrast, breast cancer was the most commonly diagnosed cancer among women aged 35 to 64 years, while colorectal cancer was the most common among women aged 65 years and above. Thyroid and breast cancers showed an inverted U-shaped incidence rate by age (Fig. 4B).
5. Survival rates
The 5-year relative survival rates for all cancer combined improved remarkably in both sexes, from 41.2% in 1993-1995 to 70.6% in 2012-2016 (Table 8). After excluding thyroid cancer, the 5-year relative survival rates for all cancer still increased from 1999 to 2016 (Fig. 5B).
The 5-year relative survival rate during 2012-2016 for all cancer combined was 63.2% in men and 78.0% in women, respectively. The 5-year relative survival rate for thyroid cancer was over 100%, while the 5-year relative survival rates for testis, prostate, and breast cancer were over 90% in 2012-2016 for both sexes, respectively. However, the 5-year relative survival rate for pancreatic cancer was only 11.4% in both sexes in 2012-2016.
When compared to the 5-year relative survival rate for men in 1993-1995, prostate cancer diagnosed from 2012 to 2016 showed the most outstanding improvement, followed by stomach, leukemia, ‘lip, oral cavity, and pharynx,’ esophagus and liver cancer. Among women, stomach cancer diagnosed during 2012-2016 showed the greatest improvement in 5-year relative survival rates compared to those between 1993 and 1995, followed by lung, leukemia, multiple myeloma, liver, and colorectal cancer.
6. Prevalence rates
A total of 1,739,951 cancer prevalent cases were identified on January 1, 2017 (Table 1). Of these cases, 764,103 (43.9%) were men and 975,848 (56.1%) were women. The overall CR and ASR for cancer prevalence were 3,404.1 per 100,000 individuals and 2,046.2 per 100,000 individuals for both sexes, respectively, in 2016 (Table 9).
The five most common cancers for men were stomach (CR, 709.9 per 100,000), colorectal (CR, 551.8 per 100,000), prostate (CR, 304.1 per 100,000), thyroid (CR, 255.9 per 100,000), and liver cancer (CR, 190.6 per 100,000). In contrast, thyroid cancer was most common in women (CR, 1,229.7 per 100,000), followed by breast (CR, 771.0 per 100,000), colorectal (CR, 373.6 per 100,000), stomach (CR, 361.4 per 100,000), and cervix uteri cancer (CR, 206.2 per 100,000).
Analysis of the period after cancer diagnosis revealed that stomach cancer (14.1%) was the most prevalent cancer within 2 years after diagnosis, followed by thyroid (14.0%) and colorectal cancer (13.1%) (Fig. 6). Thyroid cancer (25.5%) was most prevalent for 2-5 years, followed by stomach (14.3%) and colorectal cancer (13.4%). After 5 years, thyroid cancer (23.1%) was the most prevalent cancer, followed by stomach (17.1%) and colorectal cancer (13.9%).

Conflict of interest relevant to this article was not reported.

The Community of Population-Based Regional Cancer Registries

Chang-Hoon Kim (Busan Cancer Registry, Pusan National University Hospital), Cheol-In Yoo (Ulsan Caner Registry, Ulsan University Hospital), Yong-Dae Kim (Chungbuk Cancer Registry, Chungbuk National University Hospital), Hae-Sung Nam (Daejeon/ Chungnam Cancer Registry, Chungnam National University and Hospital), Jung-Sik Huh (Jeju Cancer Registry, Jeju National University and Hospital), Jung-Ho Youm (Chonbuk Cancer Registry, Chonbuk National University Hospital), Kyu-Hyoung Lim (Kangwon Cancer Registry, Kangwon National University Hospital), Nam-Soo Hong (Deagu/Gyeongbuk Cancer Registry, Kyungpook National University Medical Center), Sun-Seog Kweon (Gwangju/ Jeonnam Cancer Registry, Chonnam National University Hwasun Hospital), Woo-Chul Kim (Incheon Cancer Registry, Inha University Hospital), Ki Soo Park (Gyeongnam Cancer Registry, Gyeongsang National University and Hospital)

Acknowledgements
The authors would like to specially thank the tumor registrars (Health information manager) of the KCCR-affiliated hospitals and non-KCCR-affiliated hospitals for data collecting, abstracting, and coding. Additionally, we acknowledge the cooperation of the National Health Insurance Service and Statistics Korea for the data support.
This work was supported by the Health Promotion Fund, Ministry of Health & Welfare (No. 1860390) and research grant (No. 1910130) from the National Cancer Center, Republic of Korea.
Fig. 1.
Annual age-standardized cancer incidence and death rates by sex for all sites from 1983 to 2016 in Korea. Age standardization was based on the Segi’s world standard population.
crt-2019-138f1.jpg
Fig. 2.
Trends in age-standardized incidences of selected cancers by sex from 1999 to 2016 in Korea. (A) Men. (B) Women. Age standardization was based on the Segi’s world standard population.
crt-2019-138f2.jpg
Fig. 3.
Annual age-standardized cancer mortalities of selected cancers by sex from 1983 to 2016 in Korea. (A) Men. (B) Women. Age standardization was based on the Segi’s world standard population.
crt-2019-138f3.jpg
Fig. 4.
Age-specific incidence rates of common cancers for 2016 in Korea. (A) Men. (B) Women.
crt-2019-138f4.jpg
Fig. 5.
Trends in relative survival by year of diagnosis from 1999 to 2016. (A) All sites for both sexes. (B) All sites except thyroid cancer for both sexes.
crt-2019-138f5.jpg
Fig. 6.
Prevalence of common cancer sites by time period after cancer diagnosis. Prevalent cases were defined as the number of cancer patients alive on January 1, 2017 among all cancer patients diagnosed between 1999 and 2016.
crt-2019-138f6.jpg
Table 1.
Cancer incidence, deaths, and prevalence by sex in Korea, 2016
Site/Type New cases
Deaths
Prevalent casesa)
Both sexes Men Women Both sexes Men Women Both sexes Men Women
All sites 229,180 120,068 109,112 78,194 48,208 29,986 1,739,951 764,103 975,848
Lip, oral cavity, and pharynx 3,543 2,527 1,016 1,203 909 294 23,639 15,847 7,792
Esophagus 2,499 2,245 254 1,524 1,379 145 9,777 8,780 997
Stomach 30,504 20,509 9,995 8,264 5,318 2,946 273,701 181,234 92,467
Colon and rectum 28,127 16,672 11,455 8,358 4,659 3,699 236,431 140,852 95,579
Liver 15,771 11,774 3,997 11,001 8,044 2,957 64,864 48,666 16,198
Gallbladderb) 6,685 3,490 3,195 4,408 2,248 2,160 21,011 10,776 10,235
Pancreas 6,655 3,384 3,271 5,614 2,901 2,713 10,595 5,502 5,093
Larynx 1,167 1,101 66 334 310 24 10,532 9,914 618
Lung 25,780 17,790 7,990 17,963 13,324 4,639 76,544 47,438 29,106
Breast 21,839 92 21,747 2,472 16 2,456 198,006 743 197,263
Cervix uteri 3,566 - 3,566 897 - 897 52,758 - 52,758
Corpus uteri 2,771 - 2,771 313 - 313 23,135 - 23,135
Ovary 2,630 - 2,630 1,204 - 1,204 19,509 - 19,509
Prostate 11,800 11,800 - 1,745 1,745 - 77,635 77,635 -
Testis 288 288 - 14 14 - 3,204 3,204 -
Kidney 5,043 3,410 1,633 1,032 724 308 38,836 26,161 12,675
Bladder 4,361 3,488 873 1,389 1,029 360 33,543 27,347 6,196
Brain and CNS 2,015 1,104 911 1,327 720 607 11,116 5,734 5,382
Thyroid 26,051 5,538 20,513 346 104 242 379,946 65,336 314,610
Hodgkin lymphoma 312 202 110 51 33 18 2,807 1,770 1,037
Non-Hodgkin lymphoma 4,766 2,766 2,000 1,820 1,068 752 30,093 17,130 12,963
Multiple myeloma 1,535 837 698 1,010 527 483 5,798 3,050 2,748
Leukemia 3,416 1,991 1,425 1,842 1,025 817 20,751 11,553 9,198
Other and ill-defined 18,056 9,060 8,996 4,063 2,111 1,952 115,720 55,431 60,289

CNS, central nervous system.

a) Limited-duration prevalent cases on January 1, 2016. These are patients who were diagnosed between January 1, 1999 and December 31, 2016 and who were alive on January 1, 2017. Multiple primary cancer cases were counted multiple times,

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 2.
Crude and age-standardized cancer incidence rates by sex in Korea, 2016
Site/Type Crude incidence rate per 100,000
Age-standardized incidence rate per 100,000a)
Both sexes Men Women Both sexes Men Women
All sites 448.4 470.3 426.5 269.0 298.0 254.6
Lip, oral cavity, and pharynx 6.9 9.9 4.0 4.2 6.4 2.3
Esophagus 4.9 8.8 1.0 2.7 5.4 0.5
Stomach 59.7 80.3 39.1 34.0 49.6 20.5
Colon and rectum 55.0 65.3 44.8 30.7 40.4 22.4
Liver 30.9 46.1 15.6 17.6 28.5 7.8
Gallbladderb) 13.1 13.7 12.5 6.7 8.3 5.5
Pancreas 13.0 13.3 12.8 7.0 8.1 6.0
Larynx 2.3 4.3 0.3 1.3 2.6 0.1
Lung 50.4 69.7 31.2 27.1 42.3 15.4
Breast 42.7 0.4 85.0 27.7 0.2 54.9
Cervix uteri 7.0 0.0 13.9 4.6 - 9.1
Corpus uteri 5.4 0.0 10.8 3.4 - 6.8
Ovary 5.1 0.0 10.3 3.4 - 6.7
Prostate 23.1 46.2 0.0 12.5 28.2 -
Testis 0.6 1.1 0.0 0.6 1.1 -
Kidney 9.9 13.4 6.4 6.1 8.7 3.8
Bladder 8.5 13.7 3.4 4.5 8.4 1.6
Brain and CNS 3.9 4.3 3.6 3.1 3.5 2.7
Thyroid 51.0 21.7 80.2 36.6 15.6 58.1
Hodgkin lymphoma 0.6 0.8 0.4 0.5 0.6 0.4
Non-Hodgkin lymphoma 9.3 10.8 7.8 6.2 7.7 4.8
Multiple myeloma 3.0 3.3 2.7 1.7 2.0 1.4
Leukemia 6.7 7.8 5.6 5.6 6.6 4.7
Other and ill-defined 35.3 35.5 35.2 21.2 23.7 19.1

CNS, central nervous system.

a) Age-adjusted using the Segi’s world standard population,

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 3.
The top 10 leading causes of death in Korea, 2016
Rank Cause of death No. of deaths (%) Age-standardized death rate per 100,000a)
All causes 280,827 (100) 280.8
1 Cancer 78,194 (27.8) 79.8
2 Heart disease 9,807 (3.5) 9.0
3 Cerebrovascular disease 5,416 (1.9) 4.6
4 Pneumonia 29,735 (10.6) 27.8
5 Intentional self-harm (suicide) 23,415 (8.3) 21.4
6 Diabetes mellitus 16,476 (5.9) 14.3
7 Chronic lower respiratory diseases 6,992 (2.5) 6.0
8 Disease of liver 6,798 (2.4) 7.7
9 Transport accidents 5,150 (1.8) 6.8
10 Hypertensive diseases 13,092 (4.7) 17.7
Others 85,752 (30.5) 85.9

Source: Mortality Data, 2016, Statistics Korea [1].

a) Age-adjusted using the Segi’s world standard population.

Table 4.
Crude and age-standardized cancer mortality rates by sex in Korea, 2016
Site/Type Crude mortality rate per 100,000
Age-standardized mortality rate per 100,000a)
Both sexes Men Women Both sexes Men Women
All sites 153.0 188.8 117.2 79.8 115.5 53.6
Lip, oral cavity, and pharynx 2.4 3.6 1.1 1.3 2.2 0.5
Esophagus 3.0 5.4 0.6 1.6 3.2 0.2
Stomach 16.2 20.8 11.5 8.3 12.7 5.0
Colon and rectum 16.4 18.3 14.5 8.2 11.1 5.9
Liver 21.5 31.5 11.6 11.7 19.2 5.2
Gallbladderb) 8.6 8.8 8.4 4.2 5.3 3.4
Pancreas 11.0 11.4 10.6 5.7 7.0 4.6
Larynx 0.7 1.2 0.1 0.3 0.8 0.0
Lung 35.1 52.2 18.1 17.6 31.2 7.7
Breast 4.8 0.1 9.6 2.9 0.0 5.5
Cervix uteri 1.8 0.0 3.5 1.0 - 1.8
Corpus uteri 0.6 0.0 1.2 0.4 - 0.7
Ovary 2.4 0.0 4.7 1.3 - 2.5
Prostate 3.4 6.8 0.0 1.5 4.2 -
Testis 0.0 0.1 0.0 0.0 0.0 -
Kidney 2.0 2.8 1.2 1.1 1.8 0.5
Bladder 2.7 4.0 1.4 1.3 2.5 0.5
Brain and CNS 2.6 2.8 2.4 1.7 2.0 1.4
Thyroid 0.7 0.4 0.9 0.3 0.2 0.4
Hodgkin lymphoma 0.1 0.1 0.1 0.1 0.1 0.0
Non-Hodgkin lymphoma 3.6 4.2 2.9 1.9 2.6 1.4
Multiple myeloma 2.0 2.1 1.9 1.0 1.2 0.9
Leukemia 3.6 4.0 3.2 2.3 2.8 1.9
Other and ill-defined 7.9 8.3 7.6 4.3 5.3 3.5

CNS, central nervous system.

a) Age-adjusted using the world standard population,

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 5.
Trends in cancer incidence rates from 1999 to 2016 in Korea
Site/Type Both sexes
Men
Women
1999 2016 Trend 1
Trend 2
1999 2016 Trend 1
Trend 2
1999 2016 Trend 1
Trend 2
Year APC Year APC Year APC Year APC Year APC Year APC
All sites 210.5 269.0 1999-2011 3.6a) 2011-2016 –3.1a) 285.0 298.0 1999-2011 1.7a) 2011-2016 –3.0a) 161.1 254.6 1999-2011 5.8a) 2011-2016 –3.5a)
Lip, oral cavity, and pharynx 3.6 4.2 1999-2016 0.6a) - - 6.1 6.4 1999-2016 –0.1 - - 1.6 2.3 1999-2016 1.5a) - -
Esophagus 4.1 2.7 1999-2016 –2.2a) - - 8.8 5.4 1999-2016 –2.7a) - - 0.6 0.5 1999-2016 –1.5a) - -
Stomach 43.6 34.0 1999-2011 –0.2 2011-2016 –4.9a) 66.2 49.6 1999-2011 –0.4a) 2011-2016 –5.4a) 26.7 20.5 1999-2011 –0.4 2011-2016 –4.5a)
Colon and rectum 20.4 30.7 1999-2010 6.0a) 2010-2016 –4.5a) 26.2 40.4 1999-2010 6.5a) 2010-2016 –5.0a) 16.4 22.4 1999-2010 4.9a) 2010-2016 –3.9a)
Liver 27.9 17.6 1999-2010 –1.7a) 2010-2016 –4.4a) 46.8 28.5 1999-2009 –1.9a) 2009-2016 –4.1a) 12.3 7.8 1999-2010 –1.5a) 2010-2016 –4.8a)
Gallbladderb) 6.5 6.7 1999-2004 1.5 2004-2016 –0.3 8.1 8.3 1999-2016 0.1 - - 5.4 5.5 1999-2003 2.4 2003-2016 –0.5a)
Pancreas 5.6 7.0 1999-2016 1.4a) - - 7.8 8.1 1999-2016 0.5a) - - 4.0 6.0 1999-2016 2.3a) - -
Larynx 2.3 1.3 1999-2016 –3.6a) - - 4.9 2.6 1999-2016 –3.8a) - - 0.4 0.1 1999-2007 –9.0a) 2007-2016 –4.1a)
Lung 28.5 27.1 1999-2011 0.1 2011-2016 –1.4a) 51.4 42.3 1999-2005 –0.1 2005-2016 –1.6a) 12.4 15.4 1999-2011 2.0a) 2011-2016 –0.1
Breast 10.7 27.7 1999-2005 7.6a) 2005-2016 4.5a) 0.2 0.2 1999-2016 –0.8 20.9 54.9 1999-2005 7.8a) 2005-2016 4.6a)
Cervix uteri 8.5 4.6 1999-2016 –3.8a) - - - - - - - - 16.3 9.1 1999-2016 –3.6a) - -
Corpus uteri 1.4 3.4 1999-2003 8.8a) 2003-2016 4.6a) - - - - - - 2.8 6.8 1999-2003 9.1a) 2003-2016 4.7a)
Ovary 2.7 3.4 1999-2016 1.6a) - - - - - - - - 5.0 6.7 1999-2016 1.9a) - -
Prostate 3.1 12.5 1999-2009 15.1a) 2009-2016 1.0 8.4 28.2 1999-2009 13.5a) 2009-2016 0.2 - - - - - -
Testis 0.3 0.6 1999-2016 4.9a) - - 0.6 1.1 1999-2016 4.7a) - - - - - - - -
Kidney 3.0 6.1 1999-2009 6.6a) 2009-2016 1.7a) 4.5 8.7 1999-2010 6.0a) 2010-2016 0.8 1.7 3.8 1999-2008 6.9a) 2008-2016 2.2a)
Bladder 4.6 4.5 1999-2004 2.2a) 2004-2016 –1.2a) 9.0 8.4 1999-2004 2.0a) 2004-2016 –1.5a) 1.6 1.6 1999-2003 2.2 2003-2016 –1.4a)
Brain and CNS 2.9 3.1 1999-2016 0.2 - - 3.2 3.5 1999-2016 0.3 - - 2.6 2.7 1999-2016 0.1 - -
Thyroid 6.3 36.6 1999-2011 22.6a) 2011-2016 –12.6a) 2.1 15.6 1999-2012 22.5a) 2012-2016 –14.0a) 10.4 58.1 1999-2011 22.3a) 2011-2016 –13.5a)
Hodgkin lymphoma 0.2 0.5 1999-2016 4.0a) - - 0.4 0.6 1999-2016 3.2a) - - 0.1 0.4 1999-2016 5.1a) - -
Non-Hodgkin lymphoma 4.3 6.2 1999-2016 2.4a) - - 5.6 7.7 1999-2016 2.0a) - - 3.3 4.8 1999-2016 2.6a) - -
Multiple myeloma 1.0 1.7 1999-2012 3.7a) 2012-2016 0.8 1.2 2.0 1999-2012 3.5a) 2012-2016 0.5 0.8 1.4 1999-2006 6.1a) 2006-2016 2.2a)
Leukemia 4.7 5.6 1999-2016 1.0a) - - 5.5 6.6 1999-2016 1.1a) - - 3.9 4.7 1999-2016 0.8a) - -
Other and ill-defined 14.4 21.2 1999-2007 3.6a) 2007-2016 1.7a) 18.1 23.7 1999-2016 1.9a) - - 11.9 19.1 1999-2008 4.2a) 2008-2016 1.7a)

APC was calculated using age-standardized incidence data based on the Segi’s world standard population. APC, annual percentage change; CNS, central nervous system.

a) Significantly different from zero (p < 0.05),

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 6.
Trends in cancer mortality rates from 1999 to 2016 in Korea
Site/Type Both sexes
Men
Women
1999 2016 Trend 1
Trend 2
1999 2016 Trend 1
Trend 2
1999 2016 Trend 1
Trend 2
Year APC Year APC Year APC Year APC Year APC Year APC
All sites 114.3 79.8 1999-2002 1.1 2002-2016 –2.7a) 176.6 115.5 1999-2002 1.3 2002-2016 –3.2a) 70.6 53.6 1999-2002 1.0 2002-2016 –2.2a)
Lip, oral cavity, and pharynx 1.1 1.3 1999-2016 –1.8a) - - 2.0 2.2 1999-2016 –2.0a) - - 0.4 0.5 1999-2016 –2.5a) - -
Esophagus 3.1 1.6 1999-2016 –4.3a) - - 6.8 3.2 1999-2016 –4.6a) - - 0.5 0.2 1999-2010 –6.4a) 2010-2016 –0.6
Stomach 23.8 8.3 1999-2003 –3.2a) 2003-2016 –6.7a) 36.9 12.7 1999-2003 –2.5a) 2003-2016 –7.1a) 14.6 5.0 1999-2003 –4.4a) 2003-2016 –6.6a)
Colon and rectum 7.7 8.2 1999-2004 5.8a) 2004-2016 –1.5a) 10.5 11.1 1999-2010 1.9a) 2010-2016 –3.8a) 6.0 5.9 1999-2004 5.1a) 2004-2016 –2.0a)
Liver 20.4 11.7 1999-2002 1.0 2002-2016 –3.8a) 35.3 19.2 1999-2002 0.2 2002-2016 –3.9a) 8.3 5.2 1999-2002 2.9 2002-2016 –3.8a)
Gallbladderb) 5.2 4.2 1999-2001 6.9 2001-2016 –2.6a) 6.8 5.3 1999-2001 5.5 2001-2016 –2.6a) 4.1 3.4 1999-2001 9.0 2001-2016 –2.6a)
Pancreas 5.4 5.7 1999-2016 0.3a) - - 7.6 7.0 1999-2016 –0.4a) - - 3.9 4.6 1999-2016 0.9a) - -
Larynx 1.6 0.3 1999-2016 –9.5a) - - 3.4 0.8 1999-2016 –9.1a) - - 0.4 0.0 1999-2010 –15.3a) 2010-2016 –8.0a)
Lung 22.4 17.6 1999-2002 1.9 2002-2016 –2.1a) 41.5 31.2 1999-2001 4.3 2001-2016 –2.5a) 9.4 7.7 1999-2002 2.6 2002-2016 –1.7a)
Breast 2.2 2.9 1999-2016 1.4a) - - 0.1 0.0 1999-2016 –4.3a) - - 4.2 5.5 1999-2016 1.6a) - -
Cervix uteri 1.4 1.0 1999-2003 8.3a) 2003-2016 –5.1a) - - - - - - 2.6 1.8 1999-2003 7.7a) 2003-2016 –4.8a)
Corpus uteri 0.1 0.4 1999-2002 52.0a) 2002-2016 3.4a) - - - - - - 0.1 0.7 1999-2002 51.7a) 2002-2016 3.7a)
Ovary 0.9 1.3 1999-2001 10.2 2001-2016 0.4 - - - - - - 1.7 2.5 1999-2006 1.0a) - -
Prostate 0.9 1.5 1999-2004 9.7a) 2004-2016 0.1 2.6 4.2 1999-2004 9.6a) 2002-2016 –0.4 - - - - - -
Testis 0.0 0.0 1999-2016 –2.6 - - 0.1 0.0 1999-2016 –3.1a) - - - - - - - -
Kidney 1.1 1.1 1999-2016 –0.1 - - 1.8 1.8 1999-2016 0.0 - - 0.5 0.5 1999-2016 –0.7 - -
Bladder 1.3 1.3 1999-2011 10.0 2011-2016 –1.7a) 2.6 2.5 1999-2016 –1.6a) - - 0.5 0.5 1999-2001 10.3 2001-2016 –1.7a)
Brain and CNS 1.9 1.7 1999-2002 4.2 2002-2016 –1.9a) 2.2 2.0 1999-2016 –1.5a) - - 1.6 1.4 1999-2016 –1.4a) - -
Thyroid 0.4 0.3 1999-2003 7.4a) 2003-2016 –4.4a) 0.3 0.2 1999-2003 10.3 2003-2016 –4.5a) 0.5 0.4 1999-2004 4.5 2004-2016 –4.9a)
Hodgkin lymphoma 0.0 0.1 1999-2004 22.5a) 2004-2016 –1.4 0.0 0.1 1999-2004 19.5a) 2004-2016 –2.3 0.0 0.0 1999-2003 43.6a) 2003-2016 0.0
Non-Hodgkin lymphoma 2.1 1.9 1999-2016 –0.5a) - - 3.0 2.6 1999-2016 –0.8a) - - 1.4 1.4 1999-2016 –0.2 - -
Multiple myeloma 0.6 1.0 1999-2003 12.7a) 2003-2016 0.9 0.8 1.2 1999-2003 11.0a) 2003-2016 0.8 0.4 0.9 1999-2005 9.8a) 2005-2016 0.3
Leukemia 2.9 2.3 1999-2016 –1.7a) - - 3.5 2.8 1999-2016 –1.6a) - - 2.4 1.9 1999-2016 –1.9a)
Other and ill-defined 7.8 4.3 1999-2016 –3.1a) - - 9.0 5.3 1999-2008 –0.3 2009-2016 –5.7a) 7.0 3.5 1999-2005 –7.0a) 2005-2016 –2.1a)

APC was calculated using age-standardized incidence data based on the Segi’s world standard population. APC, annual percentage change; CNS, central nervous system.

a) Significantly different from zero (p < 0.05),

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 7.
The five common sites of cancer incidence by age group and sex in Korea, 2016
Rank Age (yr)
0-14 15-34 35-64 ≥ 65
Men
 1 Leukemia (5.2) Thyroid (13.7) Stomach (85.6) Lung (435.1)
 2 Non-Hodgkin lymphoma (2.9) Leukemia (3.8) Colon and rectum (65.1) Stomach (353.1)
 3 Brain and CNS (2.3) Non-Hodgkin lymphoma (3.1) Liver (55.6) Prostate (313.4)
 4 Kidney (0.6) Colon and rectum (2.6) Lung (44.0) Colon and rectum (302.6)
 5 Liver (0.4) Testis (2.3) Thyroid (33.3) Liver (175.5)
Women
 1 Leukemia (4.5) Thyroid (50.5) Breast (147.5) Colon and rectum (175.2)
 2 Brain and CNS (2.0) Breast (12.0) Thyroid (127.9) Stomach (137.2)
 3 Non-Hodgkin lymphoma (1.2) Cervix uteri (5.7) Colon and rectum (37.6) Lung (126.8)
 4 Ovary (0.5) Ovary (3.3) Stomach (37.6) Breast (89.5)
 5 Kidney (0.4) Leukemia (2.8) Lung (24.9) Liver (65.6)

CNS, central nervous system.

Table 8.
Trends in the 5-year relative survival rates (%) by year of diagnosis from 1993 to 2016 in Korea
Site/Type Both sexes
Men
Women
1993-1995 1996-2000 2001-2005 2006-2010 2011-2015 2012-2016 Changea) 1993-1995 1996-2000 2001-2005 2006-2010 2011-2015 2012-2016 Changea) 1993-1995 1996-2000 2001-2005 2006-2010 2011-2015 2012-2016 Changea)
All sites 41.2 44.0 54.0 65.2 70.7 70.6 29.4 31.7 35.3 45.4 56.6 62.9 63.2 31.5 53.4 55.3 64.2 74.3 78.3 78.0 24.6
Lip, oral cavity, and pharynx 41.1 46.7 54.3 60.8 64.9 65.4 24.3 35.8 41.1 49.5 56.7 61.3 62.1 26.3 58.1 63.8 67.9 71.8 74.2 73.9 15.8
Esophagus 12.7 15.2 21.4 29.7 36.4 37.4 24.7 11.8 14.3 20.6 29.1 36.1 37.2 25.4 23.7 24.2 29.8 36.9 39.4 39.6 15.9
Stomach 42.8 46.6 57.8 68.1 75.7 76.0 33.2 43.0 46.9 58.5 68.8 76.6 76.9 33.9 42.6 46.0 56.5 66.8 73.8 73.9 31.3
Colon and rectum 54.8 58.0 66.7 73.6 76.2 75.9 21.1 55.3 59.0 68.6 75.5 77.9 77.8 22.5 54.2 56.8 64.3 70.8 73.6 73.2 19.0
Liver 10.7 13.2 20.4 28.1 34.0 34.6 23.9 9.9 12.9 20.3 28.1 34.5 35.2 25.3 13.6 14.2 20.9 28.2 32.6 32.7 19.1
Gallbladderb) 17.3 19.7 23.0 26.7 28.8 29.0 11.7 16.6 20.3 23.4 27.6 29.5 29.7 13.1 18.0 19.1 22.6 25.8 28.0 28.3 10.3
Pancreas 9.4 7.6 8.4 8.4 10.7 11.4 2.0 8.8 7.3 8.4 8.2 10.3 11.2 2.4 10.1 8.1 8.4 8.7 11.2 11.7 1.6
Larynx 59.7 62.3 66.2 72.8 75.2 75.7 16.0 60.2 62.8 66.8 73.1 75.7 76.3 16.1 55.4 57.8 58.5 67.7 67.9 65.8 10.4
Lung 11.3 12.7 16.5 20.1 27.1 28.2 16.9 10.4 11.6 15.2 17.9 23.0 23.7 13.3 14.2 16.2 20.1 25.8 36.5 38.6 24.4
Breast 77.9 83.2 88.6 91.1 92.5 92.7 14.8 75.1 85.6 87.2 89.5 86.3 89.3 14.2 78.0 83.2 88.6 91.1 92.6 92.7 14.7
Cervix uteri 77.5 80.0 81.4 80.6 80.1 79.8 2.3 - - - - - - - 77.5 80.0 81.4 80.6 80.1 79.8 2.3
Corpus uteri 81.5 81.8 84.7 86.4 87.8 87.5 6.0 - - - - - - - 81.5 81.8 84.7 86.4 87.8 87.5 6.0
Ovary 58.7 58.9 61.6 61.1 63.9 64.0 5.3 - - - - - - - 58.7 58.9 61.6 61.1 63.9 64.0 5.3
Prostate 55.9 67.2 80.4 91.1 94.0 93.9 38.0 55.9 67.2 80.4 91.1 94.0 93.9 38.0 - - - - - - -
Testis 85.4 90.4 90.7 93.1 95.3 95.2 9.8 85.4 90.4 90.7 93.1 95.3 95.2 9.8 - - - - - - -
Kidney 62.0 66.1 73.5 78.3 82.3 82.7 20.7 60.8 64.4 72.9 78.2 81.8 82.5 21.7 64.5 69.7 74.8 78.7 83.3 83.1 18.6
Bladder 69.1 73.1 75.7 76.6 76.0 76.0 6.9 70.0 74.8 77.4 78.6 77.9 78.0 8.0 65.5 66.3 68.8 68.6 68.1 68.1 2.6
Brain and CNS 38.5 39.0 41.0 42.8 41.1 41.4 2.9 37.2 37.5 40.2 41.3 39.4 39.3 2.1 40.2 40.7 41.8 44.4 43.1 43.9 3.7
Thyroid 94.2 94.9 98.3 99.9 100.2 100.2 6.0 87.2 89.5 95.9 100.0 100.6 100.5 13.3 95.4 95.9 98.7 99.9 100.1 100.1 4.7
Hodgkin lymphoma 68.0 71.2 76.6 80.9 82.3 83.0 15.0 67.6 68.1 74.6 80.7 82.2 81.9 14.3 68.6 77.4 80.7 81.4 82.5 85.0 16.4
Non-Hodgkin lymphoma 46.6 50.8 55.9 59.3 62.7 63.1 16.5 45.3 48.9 54.9 59.0 62.7 63.2 17.9 48.7 53.5 57.4 59.6 62.8 63.0 14.3
Multiple myeloma 22.1 19.8 29.6 34.9 41.1 41.9 19.8 21.1 17.8 29.7 35.0 40.3 40.3 19.2 23.3 22.1 29.4 34.8 41.9 43.6 20.3
Leukemia 26.5 33.3 41.9 47.6 51.5 51.9 25.4 26.2 32.3 41.8 46.9 51.8 52.5 26.3 26.8 34.6 42.2 48.6 51.1 51.1 24.3
Other and ill-defined 42.1 45.9 57.6 67.2 72.4 73.3 31.2 37.4 42.4 53.8 63.4 69.1 70.1 32.7 47.4 50.0 61.7 71.1 75.7 76.4 29.0

CNS, central nervous system.

a) Percentage change in 5-year relative survival from 1993 to 1995 and 2012 to 2016,

b) Includes the gallbladder and other/unspecified parts of the biliary tract.

Table 9.
Crude and age-standardized rates of cancer prevalence by sex on January 1, 2017 in Korea
Site/Type Crude prevalence rate per 100,000a)
Age-standardized prevalence rate per 100,000b)
Both sexes Men Women Both sexes Men Women
All sites 3,404.1 2,993.2 3,814.1 2,046.2 1,896.1 2,281.5
Lip, oral cavity, and pharynx 46.2 62.1 30.5 28.2 39.7 18.2
Esophagus 19.1 34.4 3.9 10.5 20.9 1.9
Stomach 535.5 709.9 361.4 297.8 433.6 185.7
Colon and rectum 462.6 551.8 373.6 254.8 338.9 186.9
Liver 126.9 190.6 63.3 74.7 119.1 34.6
Gallbladderc) 41.1 42.2 40.0 21.8 25.6 18.9
Pancreas 20.7 21.6 19.9 11.9 13.5 10.6
Larynx 20.6 38.8 2.4 11.2 23.6 1.2
Lung 149.8 185.8 113.8 82.7 113.6 58.9
Breast 387.4 2.9 771.0 239.0 1.8 470.0
Cervix uteri 103.2 - 206.2 62.6 - 122.3
Corpus uteri 45.3 - 90.4 28.0 - 55.1
Ovary 38.2 - 76.3 25.5 - 50.6
Prostate 151.9 304.1 - 76.1 180.5 -
Testis 6.3 12.6 - 5.7 11.1 -
Kidney 76.0 102.5 49.5 46.3 65.8 29.0
Bladder 65.6 107.1 24.2 34.4 65.2 10.9
Brain and CNS 21.7 22.5 21.0 18.3 19.5 17.1
Thyroid 743.3 255.9 1,229.7 487.5 171.0 801.9
Hodgkin lymphoma 5.5 6.9 4.1 4.5 5.5 3.5
Non-Hodgkin lymphoma 58.9 67.1 50.7 40.8 49.1 33.1
Multiple myeloma 11.3 11.9 10.7 6.4 7.3 5.7
Leukemia 40.6 45.3 36.0 37.4 41.8 33.0
Other and ill-defined 226.4 217.1 235.6 139.9 149.0 132.6

CNS, central nervous system.

a) Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2016 and who were alive on January 1, 2017. Multiple primary cancer cases were counted multiple times,

b) Age-adjusted using the Segi’s world standard population,

c) Includes the gallbladder and other/unspecified parts of the biliary tract.

  • 1. Global cancer observatory [Internet]. Lyon: International Agency for Research on Cancer; 2018. [cited 2019 Jan 23]. Available from: https://gco.iarc.fr/
  • 2. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424. ArticlePubMed
  • 3. Jung KW, Won YJ, Kong HJ, Lee ES; Community of Population-Based Regional Cancer Registires. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2015. Cancer Res Treat. 2018;50:303–16. ArticlePubMedPMCPDF
  • 4. Jung KW, Won YJ, Oh CM, Kong HJ, Cho H, Lee JK, et al. Prediction of cancer incidence and mortality in Korea, 2016. Cancer Res Treat. 2016;48:451–7. ArticlePubMedPMCPDF
  • 5. Shin HR, Won YJ, Jung KW, Kong HJ, Yim SH, Lee JK, et al. Nationwide cancer incidence in Korea, 1999~2001: first result using the national cancer incidence database. Cancer Res Treat. 2005;37:325–31. ArticlePubMedPMCPDF
  • 6. Ajiki W, Tsukuma H, Oshima A. Index for evaluating completeness of registration in population-based cancer registries and estimation of registration rate at the Osaka Cancer Registry between 1966 and 1992 using this index. Nihon Koshu Eisei Zasshi. 1998;45:1011–7. PubMed
  • 7. Statistics Korea [Internet]. Daejeon: Statistics Korea; 2017. [cited 2019 Feb 15]. Available from: http://kosis.kr
  • 8. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International classification of diseases for oncology. 3rd ed. 1st revisionGeneva: World Health Organization; 2013.
  • 9. World Health Organization. International statistical classification of diseases and related health problems. 10th rev. ed. Geneva: World Health Organization; 1994.
  • 10. Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, et al. SEER Cancer Statistics Review, 1975-2013 [Internet]. Bethesda, MD: National Cancer Institute; 2016. [cited 2017 Feb 20]. Available from: http://seer.cancer.gov/csr/1975_2013/
  • 11. Segi M. Cancer mortality for selected sites in 24 countries (1950-1957). Sendai: Tohoku University School of Medicine; 1960.
  • 12. Day NE. Cumulative rates and cumulative risk. In: Muir C, Waterhouse J, Mack T, Powell J, Whelan S, editors. Cancer incidence in five continents, Vol. V. IARC Scientific Publications No. 88. Lyon: International Agency for Research on Cancer; 1987. p. 787–9.
  • 13. Ederer F, Heise H. Instructions to IBM 650 programmers in processing survival computations. Methodological note No. 10. Bethesda, MD: National Cancer Institute; 1959.
  • 14. Paul Dickman [Internet]. Stockholm: PaulDickman.com; 2016. [cited 2019 Feb 15]. Available from: http://www.pauldickman.com

Figure & Data

REFERENCES

    Citations

    Citations to this article as recorded by  
    • Efficacy and Safety of Programmed Death-1 (PD-1)/Programmed Death-Ligand 1 (PD-L1) Checkpoint Inhibitors in Patients With Metastatic Castration-resistant Prostate Cancer: A Systematic Review and Meta-analysis
      X. Hong, Y. Zhang, Z. Chi, Q. Xu, W. Lin, Y. Huang, T. Lin, Y. Zhang
      Clinical Oncology.2024; 36(1): e20.     CrossRef
    • A Randomized Comparison of Multimodal Analgesia and Fentanyl-Based Patient-Controlled Analgesia in Women Undergoing Robot-Assisted Bilateral Axillary Breast Approach Thyroidectomy
      Na-Young Tae, Jin Wook Yi, Jong-Kwon Jung, Junhyung Lee, Sooman Jo, Hyunzu Kim
      Journal of Clinical Medicine.2024; 13(3): 702.     CrossRef
    • Changes in the Epidemiologic Pattern of Primary CNS Tumors in Response to the Aging Population: An Updated Nationwide Cancer Registry Data in the Republic of Korea
      Yoon Hwan Byun, Johyun Ha, Ho Kang, Chul-Kee Park, Kyu-Won Jung, Heon Yoo
      JCO Global Oncology.2024;[Epub]     CrossRef
    • Analysis of tumor mutational burden and mutational landscape comparing whole-exome sequencing and comprehensive genomic profiling in patients with resectable early-stage non-small-cell lung cancer
      Su-Jin Choi, Jii Bum Lee, Jae Hwan Kim, Min Hee Hong, Byoung Chul Cho, Sun Min Lim
      Therapeutic Advances in Medical Oncology.2024;[Epub]     CrossRef
    • Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
      Freddie Bray, Mathieu Laversanne, Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel, Isabelle Soerjomataram, Ahmedin Jemal
      CA: A Cancer Journal for Clinicians.2024; 74(3): 229.     CrossRef
    • Health Inequities in Cancer Incidence According to Economic Status and Regions Are Still Existed Even under Universal Health Coverage System in Korea: A Nationwide Population Based Study Using the National Health Insurance Database
      Youngs Chang, Soo-Hee Hwang, Sang-A Cho, Hyejin Lee, Eunbyul Cho, Jin Yong Lee
      Cancer Research and Treatment.2024; 56(2): 380.     CrossRef
    • Socioeconomic inequalities in cancer incidence and mortality: An analysis of GLOBOCAN 2022
      Wei Cao, Kang Qin, Feng Li, Wanqing Chen
      Chinese Medical Journal.2024; 137(12): 1407.     CrossRef
    • Symptom burden, palliative care knowledge, and palliative care needs in advanced gynecological cancer patients in Korea
      Eungil Ko, Yaelim Lee
      Supportive Care in Cancer.2024;[Epub]     CrossRef
    • Changing Trends of Thyroid Cancer Clinical Characteristics and Treatment Pattern in South Korea: Insights from an Institutional Database and the Korean Cancer Center Registry Database
      Yung Jee Kang, Nayeon Choi, Jungirl Seok, Sun Wook Kim, Tae-Hyuk Kim, Jae Hoon Chung, Young-Ik Son, Man Ki Chung
      International Journal of Thyroidology.2024; 17(2): 277.     CrossRef
    • Associations Between Chronic Rhinosinusitis and Cancers: A Nationwide Population‐Based Cohort Study
      Yung Jin Jeon, Yeon‐Hee Joo, Hyun‐Jin Cho, Sang‐Wook Kim, Bumjung Park, Hyo Geun Choi
      The Laryngoscope.2023; 133(5): 1044.     CrossRef
    • Association between oral cavity cancer and metabolic syndrome
      Gang Won Choi, Hyeon-Kyoung Cheong, Soo Young Choi, Young Chan Lee, In-Hwan Oh, Young-Gyu Eun
      Journal of Cancer Research and Clinical Oncology.2023; 149(7): 4005.     CrossRef
    • Long-term Survivorship and Non-cancer Competing Mortality in Head and Neck Cancer: A Nationwide Population-Based Study in South Korea
      Yuh-Seog Jung, Dahhay Lee, Kyu-Won Jung, Hyunsoon Cho
      Cancer Research and Treatment.2023; 55(1): 50.     CrossRef
    • Risks of colorectal cancer and biliary cancer according to accompanied primary sclerosing cholangitis in Korean patients with ulcerative colitis: a nationwide population-based study
      Eun Hye Oh, Ye-Jee Kim, Minju Kim, Seung Ha Park, Tae Oh Kim, Sang Hyoung Park
      Intestinal Research.2023; 21(2): 252.     CrossRef
    • Comparisons of pathologic findings and outcomes of gastric cancer patients younger and older than 40: a propensity score matching study in a single center of Korea
      Yo H Kim, Yu M Jung, Tae Y Park, Su J Jeong, Tae H Kim, Jin Lee, Jongha Park, Tae O Kim, Yong E Park
      JGH Open.2023; 7(2): 118.     CrossRef
    • Application of a developed triple-classification machine learning model for carcinogenic prediction of hazardous organic chemicals to the US, EU, and WHO based on Chinese database
      Ning Hao, Peixuan Sun, Wenjin Zhao, Xixi Li
      Ecotoxicology and Environmental Safety.2023; 255: 114806.     CrossRef
    • Relative survival analysis of gynecological cancers in an urban district of Shanghai during 2002–2013
      Yu-Fei Jiang, Yu Jiang, Jing-Hao Bi, Yun Zhang, Wen-Wei Zheng, Xiao-Hui Zhou, Jing Wu, Hui-Yun Yuan, Wen-Sui Zhao, Yong-Bing Xiang
      Cancer Epidemiology.2023; 84: 102355.     CrossRef
    • Trends and Patterns of Cancer Burdens by Region and Income Level in Korea: A National Representative Big Data Analysis
      Yoon-Sun Jung, Seok-Jun Yoon
      Cancer Research and Treatment.2023; 55(2): 408.     CrossRef
    • Survival rate of thyroid cancer in the Asian countries: a systematic review and meta-analysis study
      Soheil Hassanipour, Reza Zare, Alireza Shahedi, Hamed Delam
      Endocrine.2023; 82(2): 237.     CrossRef
    • Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer Without Tumor Pd-L1 Expression in Asia
      Ying Cheng, James Chih-Hsin Yang, Isamu Okamoto, Li Zhang, Jie Hu, Donglin Wang, Chengping Hu, Jianying Zhou, Lin Wu, Lejie Cao, Jiwei Liu, Helong Zhang, Hong Sun, Ziping Wang, Hongjun Gao, Yan Yan, Suijun Xiao, Jianxin Lin, M. Catherine Pietanza, Takayas
      Immunotherapy.2023; 15(13): 1029.     CrossRef
    • N6-methyladenosine Methylation of Viral Genes
      Jiting Sun, Yan Zhang, Bing Luo
      Future Virology.2023; 18(12): 809.     CrossRef
    • Characteristics of second primary breast cancer after ovarian cancer: a Korea central cancer registry retrospective study
      Eun-Gyeong Lee, Jiwon Lim, Hyeong In Ha, Myong Cheol Lim, Yoon Jung Chang, Young-Joo Won, So-Youn Jung
      Frontiers in Oncology.2023;[Epub]     CrossRef
    • Risk of gastric cancer among long-term proton pump inhibitor users: a population-based cohort study
      Jong Wook Kim, Hye-Kyung Jung, Bora Lee, Cheol Min Shin, Eun Jeong Gong, Jitaek Hong, Young Hoon Youn, Kwang Jae Lee
      European Journal of Clinical Pharmacology.2023; 79(12): 1699.     CrossRef
    • Gastric Cancer Incidence and Mortality After Endoscopic Resection of Gastric Adenoma: A Nationwide Cohort Study
      Jae Myung Park, Songhee Cho, Ga-Yeong Shin, Jayoun Lee, Minjee Kim, Hyeon Woo Yim
      American Journal of Gastroenterology.2023; 118(12): 2166.     CrossRef
    • Communication with cancer patients: the perspective of caregivers versus non-caregivers in Iran
      Azam Naghavi, Samaneh Salimi, Winfried Rief, Pia von Blanckenburg
      Frontiers in Psychology.2023;[Epub]     CrossRef
    • Weighing the benefits of lymphadenectomy in early-stage colorectal cancer
      Seung Min Baik, Ryung-Ah Lee
      Annals of Surgical Treatment and Research.2023; 105(5): 245.     CrossRef
    • Lymphovascular invasion is an independent prognostic factor in breast cancer irrespective of axillary node metastasis and molecular subtypes
      Suk Jun Lee, Jieon Go, Byung Soo Ahn, Jee Hyun Ahn, Jee Ye Kim, Hyung Seok Park, Seung Il Kim, Byeong-Woo Park, Seho Park
      Frontiers in Oncology.2023;[Epub]     CrossRef
    • Classification and endoscopic diagnosis of colorectal polyps
      Ji Hyun Kim, Sung Chul Park
      Journal of the Korean Medical Association.2023; 66(11): 633.     CrossRef
    • Updates of Chemotherapy for Pancreatic Cancer
      Min Je Sung
      Journal of Digestive Cancer Research.2023; 11(3): 147.     CrossRef
    • Anticancer Effects of Fibronectin Leucine Rich Transmembrane Protein 3 as a Novel Therapeutic Molecule in Lung Cancer and Lung Cancer-derived Stem Cell
      Joong-Won Baek, Pyung-Hwan Kim
      Biomedical Science Letters.2023; 29(4): 336.     CrossRef
    • Survival and medical costs of melanoma patients with subsequent cancer diagnoses: A South Korean population‐based retrospective cohort study
      Hae‐Young Park, Hyun‐Ju Yang, Soo Min Jeon, In Hee Lee, Jin‐Won Kwon
      Asia-Pacific Journal of Clinical Oncology.2022;[Epub]     CrossRef
    • Risk of Kidney Failure in Patients With Cancer: A South Korean Population-Based Cohort Study
      Chang Seong Kim, Bongseong Kim, Sang Heon Suh, Tae Ryom Oh, Minah Kim, Hong Sang Choi, Eun Hui Bae, Seong Kwon Ma, Kyung-Do Han, Soo Wan Kim
      American Journal of Kidney Diseases.2022; 79(4): 507.     CrossRef
    • Synthesis and characterization of curcumin-loaded pH/reduction dual-responsive folic acid modified carboxymethyl cellulose-based microcapsules for targeted drug delivery
      Qingye Meng, Shuangling Zhong, Shihao He, Yan Gao, Xuejun Cui
      Journal of Industrial and Engineering Chemistry.2022; 105: 251.     CrossRef
    • Detection of volatile organic compounds from human prostate cancer cell using canine olfaction
      Seongsoo Jeong, Dongwook Kim, Wun-Jae Kim, Gonhyung Kim
      Journal of Veterinary Behavior.2022; 49: 80.     CrossRef
    • Mobile web‐based self‐management program for breast cancer patients with chemotherapy‐induced amenorrhoea: A quasi‐experimental study
      Jin‐Hee Park, Yong Sik Jung, Ji Young Kim, Sun Hyoung Bae
      Nursing Open.2022; 9(1): 655.     CrossRef
    • Prediction of Pathologic Findings with MRI-Based Clinical Staging Using the Bayesian Network Modeling in Prostate Cancer: A Radiation Oncologist Perspective
      Chan Woo Wee, Bum-Sup Jang, Jin Ho Kim, Chang Wook Jeong, Cheol Kwak, Hyun Hoe Kim, Ja Hyeon Ku, Seung Hyup Kim, Jeong Yeon Cho, Sang Youn Kim
      Cancer Research and Treatment.2022; 54(1): 234.     CrossRef
    • Incidence rate and factors associated with the development of secondary cancers after radioiodine therapy in differentiated thyroid cancer: a multicenter retrospective study
      Chae Moon Hong, Ji-Yeon Shin, Byeong Il Kim, Ho-Chun Song, Joon-Kee Yoon, Kyoung Sook Won, Seong-Min Kim, Ihn Ho Cho, Shin Young Jeong, Sang-Woo Lee, Jaetae Lee
      European Journal of Nuclear Medicine and Molecular Imaging.2022; 49(5): 1661.     CrossRef
    • Structural and functional brain alterations associated with cancer‐associated cognitive decline in gastric cancer patients: A preliminary longitudinal neuroimaging study
      Jaeun Ahn, DeokJong Lee, Young‐Chul Jung, Kyung Ran Kim
      Brain and Behavior.2022;[Epub]     CrossRef
    • Quality of Life and Prolonged Symptoms in Korean Breast Cancer Survivors
      Min Kyeong Jang, Sue Kim, Chang Gi Park, Eileen G. Collins, Lauretta T. Quinn, Carol Estwing Ferrans
      Cancer Nursing.2022; 45(1): E124.     CrossRef
    • Real-World Efficacy Data and Predictive Clinical Parameters for Treatment Outcomes in Advanced Esophageal Squamous Cell Carcinoma Treated with Immune Checkpoint Inhibitors
      Jwa Hoon Kim, Bokyung Ahn, Seung-Mo Hong, Hwoon-Yong Jung, Do Hoon Kim, Kee Don Choi, Ji Yong Ahn, Jeong Hoon Lee, Hee Kyoung Na, Jong Hoon Kim, Yong-Hee Kim, Hyeong Ryul Kim, Hyun Joo Lee, Sung-Bae Kim, Sook Ryun Park
      Cancer Research and Treatment.2022; 54(2): 505.     CrossRef
    • Characteristics and treatment patterns in older patients with locally advanced head and neck cancer (KCSG HN13-01)
      Eun Joo Kang, Yun-Gyoo Lee, Bhumsuk Keam, Jin-Hyuk Choi, Jin-Soo Kim, Keon Uk Park, Kyoung Eun Lee, Hyo Jung Kim, Keun-Wook Lee, Min Kyoung Kim, Hee Kyung Ahn, Seong Hoon Shin, Jii Bum Lee, Jung Hye Kwon, Hye Ryun Kim, Sung-Bae Kim, Hwan Jung Yun
      The Korean Journal of Internal Medicine.2022; 37(1): 190.     CrossRef
    • Clinical efficacy of dual trigger with human chorionic gonadotropin and a gonadotropin‐releasing hormone agonist for women undergoing fertility preservation
      Yeon Hee Hong, Seul Ki Kim, Jung Ryeol Lee, Byung Chul Jee, Chang Suk Suh
      Reproductive Medicine and Biology.2022;[Epub]     CrossRef
    • The Positive Effects of Cancer Survivor Support Service on Distress in South Korea: A Nationwide Prospective Study
      Hyun Jeong Lee, Young Ae Kim, Seong Yeob Ryu, Mison Chun, Chang-Yeol Yim, Hee-Taik Kang, Jung Hun Kang, Jung-Sik Huh, Jong-Heun Kim, Kyu-Hyoung Lim, So-Youn Jung, Hyoung-Cheol Kwon, Eurah Goh, Yeon-Seung Lee, Hee Young Ju, E. Hwa Yun, Yoon Jung Chang
      Frontiers in Medicine.2022;[Epub]     CrossRef
    • Care and Management of Voice Change in Thyroid Surgery: Korean Society of Laryngology, Phoniatrics and Logopedics Clinical Practice Guideline
      Chang Hwan Ryu, Seung Jin Lee, Jae-Gu Cho, Ik Joon Choi, Yoon Seok Choi, Yong Tae Hong, Soo Yeon Jung, Ji Won Kim, Doh Young Lee, Dong Kun Lee, GIljoon Lee, Sang Joon Lee, Young Chan Lee, Yong Sang Lee, Inn Chul Nam, Ki Nam Park, Young Min Park, Eui-Suk S
      Clinical and Experimental Otorhinolaryngology.2022; 15(1): 24.     CrossRef
    • Incidence and mortality projections for major cancers among Korean men until 2034, with a focus on prostate cancer
      Sahyun Pak, Kyu-Won Jung, Eun-Hye Park, Young Hwii Ko, Young-Joo Won, Jae Young Joung
      Investigative and Clinical Urology.2022; 63(2): 175.     CrossRef
    • Influence of Preoperative Nutritional Status on Patients Who Undergo Upfront Surgery for Esophageal Squamous Cell Carcinoma
      Jin Hee Noh, Hee Kyong Na, Yong-Hee Kim, Ho June Song, Hyeong Ryul Kim, Kee Don Choi, Gin Hyug Lee, Hwoon-Yong Jung
      Nutrition and Cancer.2022; 74(8): 2910.     CrossRef
    • New Drugs for Bacillus Calmette Guérin-Unresponsive Nonmuscle Invasive Bladder Cancer
      Jaewoon Jeong, Jae Baek Ha, In Ho Chang
      The Korean Journal of Urological Oncology.2022; 20(1): 12.     CrossRef
    • Different Mortality Risks of Long-Term Exposure to Particulate Matter across Different Cancer Sites
      Miyoun Shin, Ok-Jin Kim, Seongwoo Yang, Seung-Ah Choe, Sun-Young Kim
      International Journal of Environmental Research and Public Health.2022; 19(6): 3180.     CrossRef
    • Income Disparities in Cancer Screening: A Cross-Sectional Study of the Korean National Health and Nutrition Examination Survey, 2013–2019
      Vasuki Rajaguru, Tae Hyun Kim, Jaeyong Shin, Sang Gyu Lee
      Frontiers in Public Health.2022;[Epub]     CrossRef
    • rs2671655 single nucleotide polymorphism modulates the risk for gastric cancer in Helicobacter pylori–infected individuals: a genome-wide association study in the Korean population
      Cheol Min Shin, Kyungtaek Park, Nayoung Kim, Sungho Won, Jung Hun Ohn, Sejoon Lee, Ji Hyun Park, Seung Joo Kang, Joo Sung Kim, Dong Ho Lee
      Gastric Cancer.2022; 25(3): 573.     CrossRef
    • Clinical Implication of Mutifocality for Risk of Recurrence in Patients With Papillary Thyroid Carcinoma
      Kwangsoon Kim, Ja Seong Bae, Jeong Soo Kim
      Journal of Endocrine Surgery.2022; 22(1): 10.     CrossRef
    • Cost Utility Analysis of a Pilot Study for the Korean Lung Cancer Screening Project
      Juyoung Kim, Bogeum Cho, Seon-Ha Kim, Chang-Min Choi, Yeol Kim, Min-Woo Jo
      Cancer Research and Treatment.2022; 54(3): 728.     CrossRef
    • Enzalutamide in Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer: An Asian Multiregional, Randomized Study
      Yeong-Shiau Pu, Hanjong Ahn, Weiqing Han, Shu-Pin Huang, Hsi-Chin Wu, Lulin Ma, Shunsuke Yamada, Kazutaka Suga, Li-Ping Xie
      Advances in Therapy.2022; 39(6): 2641.     CrossRef
    • Need differences by treatment phases between patients with colorectal cancer and their caregivers: A text mining analysis
      Jaehee Yoon, Heesook Son
      Asia-Pacific Journal of Oncology Nursing.2022; 9(5): 100061.     CrossRef
    • Machine Learning Model for Predicting Postoperative Survival of Patients with Colorectal Cancer
      Mohamed Hosny Osman, Reham Hosny Mohamed, Hossam Mohamed Sarhan, Eun Jung Park, Seung Hyuk Baik, Kang Young Lee, Jeonghyun Kang
      Cancer Research and Treatment.2022; 54(2): 517.     CrossRef
    • Cause of death and cause-specific mortality for primary liver cancer in South Korea: A nationwide population-based study in hepatitis B virus-endemic area
      Bo Hyun Kim, Dahhay Lee, Kyu-Won Jung, Young-Joo Won, Hyunsoon Cho
      Clinical and Molecular Hepatology.2022; 28(2): 242.     CrossRef
    • Associations between the triglyceride-glucose index and cardiovascular disease in over 150,000 cancer survivors: a population-based cohort study
      Mi-Hyang Jung, Sang-Wook Yi, Sang Joon An, Jee-Jeon Yi, Sang-Hyun Ihm, Seongwoo Han, Kyu-Hyung Ryu, Hae Ok Jung, Ho-Joong Youn
      Cardiovascular Diabetology.2022;[Epub]     CrossRef
    • Seroprevalence of Helicobacter pylori in human immunodeficiency virus-infected patients in a tertiary care hospital in Busan, South Korea
      Jeong Eun Lee, Soon Ok Lee, Yong Ki Sim, Shinwon Lee, Gwang Ha Kim, Jin Suk Kang, Sun Hee Lee
      Journal of Infection and Chemotherapy.2022; 28(8): 1143.     CrossRef
    • CD10 and Das1: a biomarker study using immunohistochemistry to subtype gastric intestinal metaplasia
      Athanasios Koulis, Natasha Di Costanzo, Catherine Mitchell, Stephen Lade, David Goode, Rita A. Busuttil, Alex Boussioutas
      BMC Gastroenterology.2022;[Epub]     CrossRef
    • The current and future incidence and mortality of gastric cancer in 185 countries, 2020–40: A population-based modelling study
      Eileen Morgan, Melina Arnold, M. Constanza Camargo, Andrea Gini, Andrew T. Kunzmann, Tomohiro Matsuda, Filip Meheus, Rob H.A. Verhoeven, Jérôme Vignat, Mathieu Laversanne, Jacques Ferlay, Isabelle Soerjomataram
      eClinicalMedicine.2022; 47: 101404.     CrossRef
    • Global changes in gene expression related to Opisthorchis felineus liver fluke infection reveal temporal heterogeneity of a mammalian host response
      Maria Y. Pakharukova, Oxana Zaparina, Nina V. Baginskaya, Viatcheslav A. Mordvinov
      Food and Waterborne Parasitology.2022; 27: e00159.     CrossRef
    • Risk of malignancy in kidney transplant recipients: a nationwide population-based cohort study
      Su Woong Jung, Hyemi Lee, Jae Myung Cha
      BMC Nephrology.2022;[Epub]     CrossRef
    • Rehabilitation of Individuals With Cancer
      Robert Samuel Mayer, Jessica Engle
      Annals of Rehabilitation Medicine.2022; 46(2): 60.     CrossRef
    • The effect of cancer on traditional, complementary and alternative medicine utilization in Korea: a fixed effect analysis using Korea Health Panel data
      Dongsu Kim, Soo-Hyun Sung, Seungwon Shin, Minjung Park
      BMC Complementary Medicine and Therapies.2022;[Epub]     CrossRef
    • Difference in the prevalence of advanced colon adenoma between patients with gastric neoplasm and healthy people
      Myeongseok Koh, Min-Chan Kim, Jin Seok Jang
      Medicine.2022; 101(21): e29308.     CrossRef
    • Risk of Psoriasis in Postgastrectomy Gastric Cancer Survivors: A Nationwide Population-Based Cohort Study
      Bo Ri Kim, Dong Ho Lee, Hyun Ik Shim, Jee Woo Kim, Sanghyun Park, Cheol Min Shin, Kyungdo Han, Sang Woong Youn
      Annals of Dermatology.2022; 34(3): 191.     CrossRef
    • Statins and the risk of gastric, colorectal, and esophageal cancer incidence and mortality: a cohort study based on data from the Korean national health insurance claims database
      Dong-sook Kim, Hyun Jung Kim, Hyeong Sik Ahn
      Journal of Cancer Research and Clinical Oncology.2022; 148(10): 2855.     CrossRef
    • Similarities and differences among the Opisthorchiidae liver flukes: insights from Opisthorchis felineus
      Maria Y. Pakharukova, Viatcheslav A. Mordvinov
      Parasitology.2022; 149(10): 1306.     CrossRef
    • Nationwide population-based incidence of cancer among patients with HIV/AIDS in South Korea
      Soon Ok Lee, Jeong Eun Lee, Shinwon Lee, Sun Hee Lee, Jin Suk Kang, Hyunjin Son, Hyungi Lee, Jinmi Kim
      Scientific Reports.2022;[Epub]     CrossRef
    • Health Care Utilization and Anti-Cancer Drug Expenditure for Six Solid Cancers in Korea From 2007 to 2019
      Juhee Park, Kyeongjun Moon, Dong-Sook Kim
      Frontiers in Oncology.2022;[Epub]     CrossRef
    • The Impact of the Association between Cancer and Diabetes Mellitus on Mortality
      Sung-Soo Kim, Hun-Sung Kim
      Journal of Personalized Medicine.2022; 12(7): 1099.     CrossRef
    • Trend Analysis and Prediction of Hepatobiliary Pancreatic Cancer Incidence and Mortality in Korea
      Hyeong Min Park, Young-Joo Won, Mee Joo Kang, Sang-Jae Park, Sun-Whe Kim, Kyu-Won Jung, Sung-Sik Han
      Journal of Korean Medical Science.2022;[Epub]     CrossRef
    • Conditional Survival of Patients Who Underwent Curative Resection for Esophageal Squamous Cell Carcinoma
      Dong Wook Shin, Hong Kwan Kim, Jongho Cho, Genehee Lee, Juhee Cho, Jung Eun Yoo, Sumin Shin, Yong Soo Choi, Young Mog Shim, Jae Ill Zo
      Annals of Surgery.2022; 276(2): e86.     CrossRef
    • Clinicopatholgic Characteristics to the Relapse on Ductal Carcinoma <i>In Situ</i>: Ki-67 Index as the Most Influential Prognostic Factor
      Minsuh Park, Geumhee Gwak, Jungbin Kim, Hyunjin Cho, Keunho Yang, Yujin Lee, Kyeongmee Park, Jiyoung Kim, Youngjoo Shin, Yeyoung Seo
      Journal of Breast Disease.2022; 10(1): 40.     CrossRef
    • Chinese and Global Burdens of Gastrointestinal Cancers From 1990 to 2019
      Wangcheng Xie, Tingsong Yang, Jieliang Zuo, Zhilong Ma, Weidi Yu, Zhengyu Hu, Zhenshun Song
      Frontiers in Public Health.2022;[Epub]     CrossRef
    • Survival Outcomes and Predictors for Recurrence of Surgically Treated Brain Metastasis From Non-Small Cell Lung Cancer
      Joonho Byun, Jong Hyun Kim, Moinay Kim, Seungjoo Lee, Young-Hoon Kim, Chang Ki Hong, Jeong Hoon Kim
      Brain Tumor Research and Treatment.2022; 10(3): 172.     CrossRef
    • Early gastric neoplasms are significant risk factor for colorectal adenoma: A prospective case-control study
      Seong-Jung Kim, Jun Lee, Dae Youb Baek, Jun Hyung Lee, Ran Hong
      Medicine.2022; 101(32): e29956.     CrossRef
    • Analysis of treatment outcomes according to the cycles of adjuvant chemotherapy in gastric cancer: a retrospective nationwide cohort study
      Tae-Hwan Kim, Mi Sun Ahn, Yong Won Choi, Seok Yun Kang, Jin-Hyuk Choi, Hyun Woo Lee, Minae Park, Hasung Kim
      BMC Cancer.2022;[Epub]     CrossRef
    • Frequent low dose alcohol intake increases gastric cancer risk: the Health Examinees-Gem (HEXA-G) study
      Hwi-Won Lee, Dan Huang, Woo-Kyoung Shin, Katherine de la Torre, Minkyo Song, Aesun Shin, Jong-Koo Lee, Daehee Kang
      Cancer Biology & Medicine.2022; 19(8): 1224.     CrossRef
    • Multiple primary cancers in men with sporadic or familial prostate cancer: Its clinical implications
      Myong Kim, Joohon Sung, Jung Kwon Kim, Hakmin Lee, Jong Jin Oh, Sangchul Lee, Sung Kyu Hong, Seok-Soo Byun
      Urologic Oncology: Seminars and Original Investigations.2022; 40(11): 489.e1.     CrossRef
    • Repurposing of Benzimidazole Anthelmintic Drugs as Cancer Therapeutics
      Bomi Song, Eun Young Park, Kwang Joon Kim, Sung Hwan Ki
      Cancers.2022; 14(19): 4601.     CrossRef
    • A scoping review on population-centered indicators for cancer care continuum
      Vasuki Rajaguru, Jieun Jang, Jeoung A. Kwon, Jae Hyun Kim, Jaeyong Shin, Mison Chun
      Frontiers in Public Health.2022;[Epub]     CrossRef
    • Should We Always Perform Preoperative Chest Computed Tomography in Patients with cT1a Renal Cell Carcinoma?
      Jae-Wook Chung, Jun-Koo Kang, Se Won Jang, Eun Hye Lee, So Young Chun, Seock Hwan Choi, Jun Nyung Lee, Bum Soo Kim, Hyun Tae Kim, See Hyung Kim, Tae-Hwan Kim, Eun Sang Yoo, Tae Gyun Kwon, Dong Jin Park, Yun-Sok Ha
      Cancers.2022; 14(22): 5558.     CrossRef
    • Projection of Cancer Incidence and Mortality From 2020 to 2035 in the Korean Population Aged 20 Years and Older
      Youjin Hong, Sangjun Lee, Sungji Moon, Soseul Sung, Woojin Lim, Kyungsik Kim, Seokyung An, Jeoungbin Choi, Kwang-Pil Ko, Inah Kim, Jung Eun Lee, Sue K. Park
      Journal of Preventive Medicine and Public Health.2022; 55(6): 529.     CrossRef
    • Dietary patterns and gastric cancer risk in a Korean population: a case–control study
      Ji Hyun Kim, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
      European Journal of Nutrition.2021; 60(1): 389.     CrossRef
    • Optimal procedure-related hospitalization using clinical pathway protocols following gastric endoscopic submucosal dissection
      Daehyun Kim, Hyoung Woo Kim, Ki Bae Kim, Joung-Ho Han, Soon Man Yoon, Hee Bok Chae, Seon Mee Park, Sei Jin Youn
      Surgical Endoscopy.2021; 35(6): 2846.     CrossRef
    • Cardiovascular risk and undertreatment of dyslipidemia in lung cancer survivors: A nationwide population-based study
      In Young Cho, Kyungdo Han, Dong Wook Shin, Sang Hyun Park, Dong Woog Yoon, Sujeong Shin, Su-Min Jeong, Jong Ho Cho
      Current Problems in Cancer.2021; 45(1): 100615.     CrossRef
    • Lifetime cancer risks from occupational radiation exposure among workers at interventional radiology departments
      Won Jin Lee, Ye Jin Bang, Eun Shil Cha, Young Min Kim, Sung Bum Cho
      International Archives of Occupational and Environmental Health.2021; 94(1): 139.     CrossRef
    • The Role of Imaging in Current Treatment Strategies for Pancreatic Adenocarcinoma
      Hyungjin Rhee, Mi-Suk Park
      Korean Journal of Radiology.2021; 22(1): 23.     CrossRef
    • Clinical Spectrum of Uveal Metastasis in Korean Patients Based on Primary Tumor Origin
      Hyun Goo Kang, Minha Kim, Suk Ho Byeon, Sung Soo Kim, Hyoung Jun Koh, Sung Chul Lee, Min Kim
      Ophthalmology Retina.2021; 5(6): 543.     CrossRef
    • Metformin usage and the risk of colorectal cancer: a national cohort study
      Jae-woo Lee, Eun-A Choi, Ye-Seul Kim, Yonghwan Kim, Hyo-Sun You, Ye-Eun Han, Hyeong-Seop Kim, Yoon-Jong Bae, Joungyoun Kim, Hee-Taik Kang
      International Journal of Colorectal Disease.2021; 36(2): 303.     CrossRef
    • The Associations of Aspirin, Statins, and Metformin With Lung Cancer Risk and Related Mortality: A Time-Dependent Analysis of Population-Based Nationally Representative Data
      Jihun Kang, Su-Min Jeong, Dong Wook Shin, Mihee Cho, Jong Ho Cho, Jehun Kim
      Journal of Thoracic Oncology.2021; 16(1): 76.     CrossRef
    • Effect of Treatment with the PD-1/PD-L1 Inhibitors on Key Health Outcomes of Cancer Patients
      Kyung-In Joung, Jong Hwa Song, Kangho Suh, Seung-Mi Lee, Ji Hyun Jun, Taehwan Park, Dong Churl Suh
      BioDrugs.2021; 35(1): 61.     CrossRef
    • Trends in Pediatric Thyroid Cancer Incidence, Treatment, and Clinical Course in Korea During 2004–2016: A Nationwide Population-Based Study
      Young Ah Lee, Hyo Ri Yun, Juneyoung Lee, Hyemi Moon, Choong Ho Shin, Sin Gon Kim, Young Joo Park
      Thyroid.2021; 31(6): 902.     CrossRef
    • Differences in Dietary Patterns Identified by the Gaussian Graphical Model in Korean Adults With and Without a Self-Reported Cancer Diagnosis
      Tung Hoang, Jeonghee Lee, Jeongseon Kim
      Journal of the Academy of Nutrition and Dietetics.2021; 121(8): 1484.     CrossRef
    • Physical and Mental Health Factors Associated with Poor Nutrition in Elderly Cancer Survivors: Insights from a Nationwide Survey
      Mikyong Byun, Eunjung Kim, Jieun Kim
      International Journal of Environmental Research and Public Health.2021; 18(17): 9313.     CrossRef
    • Therapeutic Decision Making in Hepatocellular Carcinoma According to Age and Child–Pugh Class: A Nationwide Cohort Analysis in South Korea
      Sunmin Park, Chai Hong Rim, Young Kul Jung, Won Sup Yoon, Alessandro Granito
      Canadian Journal of Gastroenterology and Hepatology.2021; 2021: 1.     CrossRef
    • Association of Aspirin, Metformin, and Statin Use with Gastric Cancer Incidence and Mortality: A Nationwide Cohort Study
      Mi Hee Cho, Tae Gon Yoo, Su-Min Jeong, Dong Wook Shin
      Cancer Prevention Research.2021; 14(1): 95.     CrossRef
    • Multivariate analysis of early surgical management factors affecting posttraumatic penoscrotal avulsion injury: a level I trauma center study
      Min Ji Kim, Dong Hwan Lee, Dong Ha Park, Il Jae Lee
      BMC Urology.2021;[Epub]     CrossRef
    • Serum concentrations of persistent organic pollutants and colorectal cancer risk: A case-cohort study within Korean National Cancer Center Community (KNCCC) cohort
      Eun Young Park, Jinsun Kim, Eunjung Park, Jin-Kyoung Oh, Byungmi Kim, Min Kyung Lim
      Chemosphere.2021; 271: 129596.     CrossRef
    • Association between changes in mammographic density category and the risk of breast cancer: A nationwide cohort study in East‐Asian women
      Soyeoun Kim, Boyoung Park
      International Journal of Cancer.2021; 148(11): 2674.     CrossRef
    • Prospective evaluation of metabolic intratumoral heterogeneity in patients with advanced gastric cancer receiving palliative chemotherapy
      Shin Hye Yoo, Seo Young Kang, Jeesun Yoon, Tae-Yong Kim, Gi Jeong Cheon, Do-Youn Oh
      Scientific Reports.2021;[Epub]     CrossRef
    • Clinical Application of Targeted Deep Sequencing in Metastatic Colorectal Cancer Patients: Actionable Genomic Alteration in K-MASTER Project
      Youngwoo Lee, Soohyeon Lee, Jae Sook Sung, Hee-Joon Chung, Ah-reum Lim, Ju Won Kim, Yoon Ji Choi, Kyong Hwa Park, Yeul Hong Kim
      Cancer Research and Treatment.2021; 53(1): 123.     CrossRef
    • Adherence to the Recommended Intake of Calcium and Colorectal Cancer Risk in the HEXA Study
      Jeeyoo Lee, Aesun Shin, Ji-Yeob Choi, Daehee Kang, Jong-Koo Lee
      Cancer Research and Treatment.2021; 53(1): 140.     CrossRef
    • Characterizing the Anticancer Treatment Trajectory and Pattern in Patients Receiving Chemotherapy for Cancer Using Harmonized Observational Databases: Retrospective Study
      Hokyun Jeon, Seng Chan You, Seok Yun Kang, Seung In Seo, Jeremy L Warner, Rimma Belenkaya, Rae Woong Park
      JMIR Medical Informatics.2021; 9(4): e25035.     CrossRef
    • A Nationwide, Population-Based Epidemiology Study of Primary Central Nervous System Tumors in Korea, 2007-2016: A Comparison with United States Data
      Ho Kang, Sang Woo Song, Johyun Ha, Young-Joo Won, Chul-Kee Park, Heon Yoo, Kyu-Won Jung
      Cancer Research and Treatment.2021; 53(2): 355.     CrossRef
    • Anterolateral thigh free flaps and radial forearm free flaps in head and neck reconstruction: A 20-year analysis from a single institution
      Simon Yang, Jong Won Hong, In Sik Yoon, Dae Hyun Lew, Tai Suk Roh, Won Jai Lee
      Archives of Plastic Surgery.2021; 48(01): 49.     CrossRef
    • Time trends of colorectal cancer incidence and associated lifestyle factors in South Korea
      Hayeong Khil, Sung Min Kim, SungEun Hong, Hyeon Min Gil, Eugene Cheon, Dong Hoon Lee, Young Ae Kim, NaNa Keum
      Scientific Reports.2021;[Epub]     CrossRef
    • Characteristics and Prognostic Factors of Recurrence after Hemithyroidectomy in Patients with Papillary Thyroid Microcarcinoma
      Jihoon Lee, Gil Joon Lee, Jin Ho Sohn, Dongbin Ahn
      Korean Journal of Otorhinolaryngology-Head and Neck Surgery.2021; 64(1): 19.     CrossRef
    • Automated detection of colorectal tumors based on artificial intelligence
      Kwang-Sig Lee, Sang-Hyuk Son, Sang-Hyun Park, Eun Sun Kim
      BMC Medical Informatics and Decision Making.2021;[Epub]     CrossRef
    • Development of Korean CARcinogen EXposure: An Initiative of the Occupational Carcinogen Surveillance System in Korea
      Dong-Hee Koh, Ju-Hyun Park, Sang-Gil Lee, Hwan-Cheol Kim, Sangjun Choi, Hyejung Jung, Inah Kim, Donguk Park
      Annals of Work Exposures and Health.2021; 65(5): 528.     CrossRef
    • Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
      Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel, Mathieu Laversanne, Isabelle Soerjomataram, Ahmedin Jemal, Freddie Bray
      CA: A Cancer Journal for Clinicians.2021; 71(3): 209.     CrossRef
    • The emergence of oral cavity cancer and the stabilization of oropharyngeal cancer: Recent contrasting epidemics in the South Korean population
      Yuh‐Seog Jung, Jungirl Seok, Seri Hong, Chang Hwan Ryu, Junsun Ryu, Kyu‐Won Jung
      Cancer.2021; 127(10): 1638.     CrossRef
    • Bioengineered gold nanoparticles using Cynodon dactylon extract and its cytotoxicity and antibacterial activities
      Ramachandran Vinayagam, Murali Santhoshkumar, Kyung Eun Lee, Ernest David, Sang Gu Kang
      Bioprocess and Biosystems Engineering.2021; 44(6): 1253.     CrossRef
    • The role of gonadotropin-releasing hormone agonists in female fertility preservation
      Jae Hoon Lee, Young Sik Choi
      Clinical and Experimental Reproductive Medicine.2021; 48(1): 11.     CrossRef
    • Surtuin 1 as a potential prognostic biomarker in very elderly patients with colorectal cancer
      Guk Jin Lee, Yun Hwa Jung, Tae-Jung Kim, Yosep Chong, Seo-Won Jeong, In Kyu Lee, In Sook Woo
      The Korean Journal of Internal Medicine.2021; 36(Suppl 1): S235.     CrossRef
    • Risk factors of advanced metachronous neoplasms in surveillance after colon cancer resection
      Kwangwoo Nam, Jeong Eun Shin
      The Korean Journal of Internal Medicine.2021; 36(2): 305.     CrossRef
    • CDX-2 Protein and mRNA Expression in Canine Intestinal Adenocarcinoma
      Seung-Hee Cho, Byung-Joon Seung, Soo-Hyeon Kim, Min-Kyung Bae, Ha-Young Lim, Jung-Hyang Sur
      Journal of Comparative Pathology.2021; 184: 24.     CrossRef
    • Characteristics of interval gastric neoplasms detected within two years after negative screening endoscopy among Koreans
      Joo Hyun Lim, Ji Hyun Song, Su Jin Chung, Goh Eun Chung, Joo Sung Kim
      BMC Cancer.2021;[Epub]     CrossRef
    • Metformin use in cancer survivors with diabetes reduces all-cause mortality, based on the Korean National Health Insurance Service between 2002 and 2015
      Joungyoun Kim, Yoon-Jong Bae, Jae-woo Lee, Ye-seul Kim, Yonghwan Kim, Hyo-Sun You, Hyeong-Seop Kim, Eun-A Choi, Ye-Eun Han, Hee-Taik Kang
      Medicine.2021; 100(11): e25045.     CrossRef
    • Serum Testosterone Level as Possible Predictive Marker for Prognosis in Metastatic Castration-Resistant Prostate Cancer Patients Treated With Enzalutamide
      Dong Hyeon An, Hwiwoo Kim, Donghyun Lee, In Gab Jeong, Dalsan You, Jun Hyuk Hong, Choung-Soo Kim, Hanjong Ahn
      The Korean Journal of Urological Oncology.2021; 19(1): 60.     CrossRef
    • Periodic Fluctuations in the Incidence of Gastrointestinal Cancer
      Mun-Gan Rhyu, Jung-Hwan Oh, Tae Ho Kim, Joon-Sung Kim, Young A Rhyu, Seung-Jin Hong
      Frontiers in Oncology.2021;[Epub]     CrossRef
    • Recent Trends of Lung Cancer in Korea
      Jae Guk Lee, Ho Cheol Kim, Chang-Min Choi
      Tuberculosis and Respiratory Diseases.2021; 84(2): 89.     CrossRef
    • The Perspective of Therapeutic Antibody Marketing in Iran: Trend and Estimation by 2025
      Monireh Golpour, Pouya Vatanpour, Mina Amini, Majid Saeedi, Nasim Hafezi, Alireza Rafiei, Benedetto Natalini
      Advances in Pharmacological and Pharmaceutical Sciences.2021; 2021: 1.     CrossRef
    • De Novo Cancer Incidence after Cholecystectomy in Korean Population
      Yun Kyung Jung, Junghyun Yoon, Kyeong Geun Lee, Han Joon Kim, Boyoung Park, Dongho Choi
      Journal of Clinical Medicine.2021; 10(7): 1445.     CrossRef
    • Radiologic Evaluation for Resectability of Pancreatic Adenocarcinoma
      Shin Hye Hwang, Mi-Suk Park
      Journal of the Korean Society of Radiology.2021; 82(2): 315.     CrossRef
    • Trends in Cancer Screening Rates among Korean Men and Women: Results of the Korean National Cancer Screening Survey, 2004–2018
      Seri Hong, Yun Yeong Lee, Jaeho Lee, Yeol Kim, Kui Son Choi, Jae Kwan Jun, Mina Suh
      Cancer Research and Treatment.2021; 53(2): 330.     CrossRef
    • A Modular Mobile Health App for Personalized Rehabilitation Throughout the Breast Cancer Care Continuum: Development Study
      Ji Young Lim, Jong Kwang Kim, Yoon Kim, So-Yeon Ahn, Jonghan Yu, Ji Hye Hwang
      JMIR Formative Research.2021; 5(4): e23304.     CrossRef
    • Real-World Clinical Data of Palbociclib in Asian Metastatic Breast Cancer Patients: Experiences from Eight Institutions
      Jieun Lee, Hyung Soon Park, Hye Sung Won, Ji Hyun Yang, Hee Yeon Lee, In Sook Woo, Kabsoo Shin, Ji Hyung Hong, Young Joon Yang, Sang Hoon Chun, Jae Ho Byun
      Cancer Research and Treatment.2021; 53(2): 409.     CrossRef
    • Association between cancer stigma and job loss among cancer survivors
      Sungkeun Shim, Danbee Kang, Ka Ryeong Bae, Woo Yong Lee, Seok Jin Nam, Tae Sung Sohn, Byong Chang Jeong, Dong Hyun Sinn, Sun Seog Kweon, Young Mog Shim, Juhee Cho
      Psycho-Oncology.2021; 30(8): 1347.     CrossRef
    • Body mass index and absolute lymphocyte count predict disease-free survival in Korean breast cancer patients
      Sung Min Ko, Janghee Lee, Soong June Bae, Su Jung Baik, Junghwan Ji, Dooreh Kim, Sung Gwe Ahn, Joon Jeong
      British Journal of Cancer.2021; 125(1): 119.     CrossRef
    • Implications of Radiotherapy Utilization in Korea from 2010 to 2019
      Jeongshim Lee, Woo Chul Kim, Won Sup Yoon, Chai Hong Rim
      Journal of Korean Medical Science.2021;[Epub]     CrossRef
    • Conditional Relative Survival of Ovarian Cancer: A Korean National Cancer Registry Study
      Dong Wook Shin, Jaeman Bae, Johyun Ha, Kyu-Won Jung
      Frontiers in Oncology.2021;[Epub]     CrossRef
    • Analyses of the Association between Thyroid Cancer and Osteoporosis/Fracture Histories: A Cross-Sectional Study Using KoGES HEXA Data
      Young-Ju Jin, Chang-Myeon Song, Bum-Jung Park, Hyo-Geun Choi
      International Journal of Environmental Research and Public Health.2021; 18(9): 4732.     CrossRef
    • Association between long-term exposure to high levels of ambient air pollution and incidence of lung cancer in a population-based cohort
      Seongwoo Yang, Ok-Jin Kim, Miyoun Shin, Woo Jin Kim, Sun-Young Kim
      Environmental Research.2021; 198: 111214.     CrossRef
    • Real‐world utility of next‐generation sequencing for targeted gene analysis and its application to treatment in lung adenocarcinoma
      Jwa Hoon Kim, Shinkyo Yoon, Dae Ho Lee, Se Jin Jang, Sung‐Min Chun, Sang‐We Kim
      Cancer Medicine.2021; 10(10): 3197.     CrossRef
    • The Impact of Primary Tumor Resection on Survival in Asymptomatic Colorectal Cancer Patients With Unresectable Metastases
      Ki Yoon Doah, Ui Sup Shin, Byong Ho Jeon, Sang Sik Cho, Sun Mi Moon
      Annals of Coloproctology.2021; 37(2): 94.     CrossRef
    • Decreasing trends in thyroid cancer incidence in South Korea: What happened in South Korea?
      Chang‐Mo Oh, Jiwon Lim, Yuh Seog Jung, Yeol Kim, Kyu‐Won Jung, Seri Hong, Young‐Joo Won
      Cancer Medicine.2021; 10(12): 4087.     CrossRef
    • Trends in Childhood Thyroid Cancer incidence in Korea and Its Potential Risk Factors
      Jun Park, Hyunju Park, Tae Hyuk Kim, Sun Wook Kim, Hye Won Jang, Jae Hoon Chung
      Frontiers in Endocrinology.2021;[Epub]     CrossRef
    • Disparities in prostate cancer diagnosis, treatment, and survival among men with disabilities: Retrospective cohort study in South Korea
      Dong Wook Shin, Jinsung Park, Kyoung Eun Yeob, Seok Jung Yoon, Soong-nang Jang, So Young Kim, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
      Disability and Health Journal.2021; 14(4): 101125.     CrossRef
    • Emerging treatments for bacillus Calmette–Guérin-unresponsive non-muscle-invasive bladder cancer
      Hyung Suk Kim, Ho Kyung Seo
      Investigative and Clinical Urology.2021; 62(4): 361.     CrossRef
    • Study on effects of miR-141-3p in proliferation, migration, invasion and apoptosis of colon cancer cells by inhibiting Bcl2
      S. J. Tong, X. Y. Zhang, H. F. Guo, J. Yang, Y. P. Qi, S. Lu
      Clinical and Translational Oncology.2021; 23(12): 2526.     CrossRef
    • Association between gallstones and the risk of biliary tract cancer: a systematic review and meta-analysis
      Dan Huang, Hyundeok Joo, Nan Song, Sooyoung Cho, Woosung Kim, Aesun Shin
      Epidemiology and Health.2021; 43: e2021011.     CrossRef
    • The impact of expanding health insurance coverage for anti‐cancer drugs on cancer survival in Korea
      Do‐Yeon Cho, Juhee Park, Dong‐Sook Kim
      Cancer Medicine.2021; 10(13): 4555.     CrossRef
    • Analyses of the association between breast cancer and osteoporosis/fracture history: a cross-sectional study using KoGES HEXA data
      Hyo Geun Choi, Yong Joon Suh, Jung Woo Lee, Chan Yang Min, Dae Myoung Yoo, Suk Woo Lee
      Archives of Osteoporosis.2021;[Epub]     CrossRef
    • Efficacy of Intraoperative Neuromonitoring during Thyroidectomy with Transcutaneous Adhesive Skin Electrodes
      Sang Gyu Seo, Hyoung Shin Lee, Ki Hun Jo, Sung Won Kim, Kang Dae Lee
      Korean Journal of Otorhinolaryngology-Head and Neck Surgery.2021; 64(6): 416.     CrossRef
    • Individual 5-Year Lung Cancer Risk Prediction Model in Korea Using a Nationwide Representative Database
      Yohwan Yeo, Dong Wook Shin, Kyungdo Han, Sang Hyun Park, Keun-Hye Jeon, Jungkwon Lee, Junghyun Kim, Aesun Shin
      Cancers.2021; 13(14): 3496.     CrossRef
    • Genetic Susceptibility of ACE2 and TMPRSS2 in Six Common Cancers and Possible Impacts on COVID-19
      Tung Hoang, Trung Quang Nguyen, Tho Thi Anh Tran
      Cancer Research and Treatment.2021; 53(3): 650.     CrossRef
    • Population Attributable Fraction of Helicobacter pylori Infection–Related Gastric Cancer in Korea: A Meta-Analysis
      Yoon Park, Moran Ki
      Cancer Research and Treatment.2021; 53(3): 744.     CrossRef
    • Application Research of Individualized Conditional Reprogramming System to Guide Treatment of Gastric Cancer
      Weizhu Zhao, Kai Liu, Zhikun Sun, Longgang Wang, Bing Liu, Luguang Liu, Xianlin Qu, Zhixiang Cao, Jujie Sun, Jie Chai
      Frontiers in Oncology.2021;[Epub]     CrossRef
    • Fear of cancer recurrence in Korean women after breast cancer treatment: A mixed methods study
      Se Jin Hong, Nah-Mee Shin
      European Journal of Oncology Nursing.2021; 54: 102010.     CrossRef
    • The Association between the Use of Dietary Supplement and Psychological Status of Cancer Survivors in Korea: A Cross-Sectional Study
      Han Rim Lee, Yun-Mi Song, Keun Hye Jeon, In Young Cho
      Korean Journal of Family Medicine.2021; 42(4): 317.     CrossRef
    • Disparities in Cancer-Related Avoidable Mortality by the Level of Area Deprivation in South Korea
      Woorim Kim, Seongkyeong Jang, Gangeun Lee, Yoon Jung Chang
      International Journal of Environmental Research and Public Health.2021; 18(15): 7856.     CrossRef
    • Validity and reliability of the Health-Related Quality of Life Instrument with 8 Items (HINT-8) in Korean breast cancer patients
      Juyoung Kim, Min-Woo Jo, Hyeon-Jeong Lee, Sei-Hyun Ahn, Byung Ho Son, Jong Won Lee, Sae Byul Lee
      Osong Public Health and Research Perspectives.2021; 12(4): 254.     CrossRef
    • Risk of Cancer in Middle-aged Patients With Gout: A Nationwide Population-based Study in Korea
      Jung Sun Lee, Jisun Myung, Hyun Ah Lee, Seokchan Hong, Chang-Keun Lee, Bin Yoo, Ji Seon Oh, Yong-Gil Kim
      The Journal of Rheumatology.2021; 48(9): 1465.     CrossRef
    • Usage of Platinum Nanoparticles for Anticancer Therapy over Last Decade: A Review
      Aditya Amrut Pawar, Jyotirmayee Sahoo, Aakash Verma, Abhijit Lodh, Jaya Lakkakula
      Particle & Particle Systems Characterization.2021;[Epub]     CrossRef
    • The incidence and survival of cervical, ovarian, and endometrial cancer in Korea, 1999-2017: Korea Central Cancer Registry
      Hyeong In Ha, Ha Kyun Chang, Soo Jin Park, Jiwon Lim, Young-Joo Won, Myong Cheol Lim
      Obstetrics & Gynecology Science.2021; 64(5): 444.     CrossRef
    • Bacteria-Derived Extracellular Vesicles in Urine as a Novel Biomarker for Gastric Cancer: Integration of Liquid Biopsy and Metagenome Analysis
      Jae-Yong Park, Chil-Sung Kang, Ho-Chan Seo, Jin-Chul Shin, Sung-Min Kym, Young-Soo Park, Tae-Seop Shin, Jae-Gyu Kim, Yoon-Keun Kim
      Cancers.2021; 13(18): 4687.     CrossRef
    • Physical Activity after Colorectal Cancer Diagnosis and Mortality in a Nationwide Retrospective Cohort Study
      Meesun Lee, Yunseo Lee, Doeun Jang, Aesun Shin
      Cancers.2021; 13(19): 4804.     CrossRef
    • Development of Population-Based Cancer Indicators and a Measurement of Cancer Care Continuum Using a Modified Delphi Method
      Vasuki Rajaguru, Jieun Jang, JaeHyun Kim, JeoungA Kwon, Oyeon Cho, SeungYeun Chung, MiSun Ahn, JinHee Park, YoungJoo Won, KyuWon Jung, Jaeyong Shin, Mison Chun
      Cancers.2021; 13(19): 4826.     CrossRef
    • Comparison of Long-Term Efficacy in S-1 and Capecitabine With Oxaliplatin as Adjuvant Chemotherapy for Patients With Gastric Cancer After Curative Surgery: A Retrospective, Single-Center Observational Study
      Sung E. Oh, Ji Y. An, Min-Gew Choi, Jun H. Lee, Tae S. Sohn, Jae M. Bae
      Technology in Cancer Research & Treatment.2021;[Epub]     CrossRef
    • Analysis of the Occurrence of Diseases Following Gastrectomy for Early Gastric Cancer: a Nationwide Claims Study
      Ho Seok Seo, Yewon Na, Jaehun Jung
      Journal of Gastric Cancer.2021;[Epub]     CrossRef
    • Ovarian Function Preservation in Patients With Cervical Cancer Undergoing Hysterectomy and Ovarian Transposition Before Pelvic Radiotherapy
      Wonguen Jung, Yun H. Kim, Kyung S. Kim
      Technology in Cancer Research & Treatment.2021;[Epub]     CrossRef
    • The Role of Prostate Combination Biopsy Consisting of Targeted and Additional Systematic Biopsy
      Chung Un Lee, Joongwon Choi, Si Hyun Sung, Jae Hoon Chung, Wan Song, Minyong Kang, Hyun Hwan Sung, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee, Hwang Gyun Jeon
      Journal of Clinical Medicine.2021; 10(21): 4804.     CrossRef
    • Tumor Microenvironment Modulating Functional Nanoparticles for Effective Cancer Treatments
      Seungyong Shin, Jiyoung Lee, Jieun Han, Fangyuan Li, Daishun Ling, Wooram Park
      Tissue Engineering and Regenerative Medicine.2021; 19(2): 205.     CrossRef
    • Physical Activity Interventions for Colorectal Cancer Survivors
      Youjin Jung, Joohyun Chung, Heesook Son
      Cancer Nursing.2021; 44(6): E414.     CrossRef
    • New approach of prediction of recurrence in thyroid cancer patients using machine learning
      Soo Young Kim, Young-Il Kim, Hee Jun Kim, Hojin Chang, Seok-Mo Kim, Yong Sang Lee, Soon-Sun Kwon, Hyunjung Shin, Hang-Seok Chang, Cheong Soo Park
      Medicine.2021; 100(42): e27493.     CrossRef
    • Nonclinical Safety Pharmacology Study of the Herbal Product HAD-B1
      Soo-Dam Kim, Jae-Ho Yang, Eun-Bin Kwag, Ji-Hye Park, So-Jung Park, Hwa-Seung Yoo, Francesca Mancianti
      Evidence-Based Complementary and Alternative Medicine.2021; 2021: 1.     CrossRef
    • Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP)
      Jae Seung Kang, Lydia Mok, Jin Seok Heo, In Woong Han, Sang Hyun Shin, Yoo-Seok Yoon, Ho-Seong Han, Dae Wook Hwang, Jae Hoon Lee, Woo Jung Lee, Sang Jae Park, Joon Seong Park, Yonghoon Kim, Huisong Lee, Young-Dong Yu, Jae Do Yang, Seung Eun Lee, Il Young
      Gut and Liver.2021; 15(6): 912.     CrossRef
    • Impact of the different biliopancreatic limb length on diabetes and incretin hormone secretion following distal gastrectomy in gastric cancer patients
      Ji Yeon Park, Oh Kyoung Kwon, Jae-Han Jeon, Yeon-Kyung Choi, Ki Bum Park
      Scientific Reports.2021;[Epub]     CrossRef
    • ‘Trend in premature mortality from four major NCDs in Nanjing, China, 2007–2018’
      Huafeng Yang, Yali Fu, Xin Hong, Hao Yu, Weiwei Wang, Fengxia Sun, Jinyi Zhou, Nan Zhou
      BMC Public Health.2021;[Epub]     CrossRef
    • Supportive Care Needs and Health-Related Quality of Life of Esophageal Cancer Survivors
      Eunju Choi, Soo H Kim, Young W Lee, Hwasoon Kim, Young M Shim, Genehee Lee, Deborah L Volker
      Asia-Pacific Journal of Oncology Nursing.2021; 8(2): 164.     CrossRef
    • The relationship between metabolic syndrome and the incidence of colorectal cancer
      JungHyun Lee, Kun Sei Lee, Hyeongsu Kim, Hyoseon Jeong, Min-Jung Choi, Hai-Won Yoo, Tae-Hwa Han, Hyunjung Lee
      Environmental Health and Preventive Medicine.2020;[Epub]     CrossRef
    • Clinical utilization of radiation therapy in Korea, 2016
      Eunji Kim, Won Il Jang, Mi-Sook Kim, Eun Kyung Paik, Hee Jin Kim, Hyung Jun Yoo, Kwangmo Yang, Chul Koo Cho
      Journal of Radiation Research.2020; 61(2): 249.     CrossRef
    • Causes of death among cancer patients in the era of cancer survivorship in Korea: Attention to the suicide and cardiovascular mortality
      Chang‐Mo Oh, Dahhay Lee, Hyun‐Joo Kong, Seokmin Lee, Young‐Joo Won, Kyu‐Won Jung, Hyunsoon Cho
      Cancer Medicine.2020; 9(5): 1741.     CrossRef
    • Comparison Study of Robotic Thyroidectomies Through a Bilateral Axillo-Breast Approach and a Transoral Approach
      Sumin Chae, Sun Young Min, Won Seo Park
      Journal of Laparoendoscopic & Advanced Surgical Techniques.2020; 30(2): 175.     CrossRef
    • Bridging the Gap between Evidence and Real-World Practice for Liver Cancer Screening in South Korea
      Chang-Mo Oh
      Gut and Liver.2020; 14(1): 5.     CrossRef
    • Association Between Fatty Liver Index and Risk of Breast Cancer: A Nationwide Population-Based Study
      Jin Hyun Park, In Sil Choi, Kyung-Do Han, Hyunkyung Park, Ki Hwan Kim, Jin-Soo Kim
      Clinical Breast Cancer.2020; 20(4): e450.     CrossRef
    • Validity and reliability of a Korean version of the breast cancer survivors resilience scale
      Jung Min Kim, Jin Hyuk Choi, Jeong‐Won Han
      Japan Journal of Nursing Science.2020;[Epub]     CrossRef
    • Prognostic significance of body mass index and prognostic nutritional index in stage II/III gastric cancer
      Su Hyung Park, Sejin Lee, Jeong Ho Song, Seohee Choi, Minah Cho, In Gyu Kwon, Taeil Son, Hyoung-Il Kim, Jae-Ho Cheong, Woo Jin Hyung, Seung Ho Choi, Sung Hoon Noh, Yoon Young Choi
      European Journal of Surgical Oncology.2020; 46(4): 620.     CrossRef
    • Prevalence and Clinicopathological Significance of MET Overexpression and Gene Amplification in Patients with Gallbladder Carcinoma
      Yeseul Kim, Seong Sik Bang, Seungyun Jee, Sungeon Park, Su-Jin Shin, Kiseok Jang
      Cancer Research and Treatment.2020; 52(2): 481.     CrossRef
    • Combination versus single-agent as palliative chemotherapy for gastric cancer
      Jin-Hyuk Choi, Yong Won Choi, Seok Yun Kang, Geum Sook Jeong, Hyun Woo Lee, Seong Hyun Jeong, Joon Seong Park, Mi Sun Ahn, Seung Soo Sheen
      BMC Cancer.2020;[Epub]     CrossRef
    • Fibroblast Growth Factor Receptor 1 (FGFR1) Amplification Detected by Droplet Digital Polymerase Chain Reaction (ddPCR) Is a Prognostic Factor in Colorectal Cancers
      Jeong Mo Bae, Xianyu Wen, Tae-Shin Kim, Yoonjin Kwak, Nam-Yun Cho, Hye Seung Lee, Gyeong Hoon Kang
      Cancer Research and Treatment.2020; 52(1): 74.     CrossRef
    • Parathyroid hormone is associated with prostate cancer
      Won Tae Kim, Woo Jin Bang, Sung Pil Seo, Ho Won Kang, Young Joon Byun, Xuan-Mei Piao, Pildu Jeong, Kyung-Sub Shin, Song-Yi Choi, Ok-Jun Lee, Yong-June Kim, Sang Cheol Lee, Seok Joong Yun, Wun-Jae Kim
      Prostate International.2020; 8(3): 116.     CrossRef
    • Occupational Class and Cancer Survival in Korean Men: Follow-Up Study of Nation-Wide Working Population
      Hye-Eun Lee, Masayoshi Zaitsu, Eun-A Kim, Ichiro Kawachi
      International Journal of Environmental Research and Public Health.2020; 17(1): 303.     CrossRef
    • Association of Screening by Thyroid Ultrasonography with Mortality in Thyroid Cancer: A Case–Control Study Using Data from Two National Surveys
      Jae Kwan Jun, Soon-Young Hwang, Seri Hong, Mina Suh, Kui Son Choi, Kyu-Won Jung
      Thyroid.2020; 30(3): 396.     CrossRef
    • Acknowledging the Unsung Role of the Cancer Registry in Rare Cancers
      Jung-Myun Kwak
      Annals of Coloproctology.2020; 36(1): 1.     CrossRef
    • Female reproductive factors and the risk of lung cancer in postmenopausal women: a nationwide cohort study
      Keun Hye Jeon, Dong Wook Shin, Kyungdo Han, Dahye Kim, Jung Eun Yoo, Su-Min Jeong, Jong ho Cho
      British Journal of Cancer.2020; 122(9): 1417.     CrossRef
    • Castration-Resistant Prostate Cancer Outcome Prediction Using Phased Long Short-Term Memory with Irregularly Sampled Serial Data
      Jihwan Park, Mi Jung Rho, Hyong Woo Moon, Ji Youl Lee
      Applied Sciences.2020; 10(6): 2000.     CrossRef
    • Dietary Mixed Cereal Grains Ameliorate the Azoxymethane and Dextran Sodium Sulfate-Induced Colonic Carcinogenesis in C57BL/6J Mice
      Jia-Le Song, Jung-Sook Lee, Hee-Young Kim, Byung-Jin Jeong, Jong-Sung Jeong, Tae-Gon Huh, Kun-Young Park
      Journal of Medicinal Food.2020; 23(4): 440.     CrossRef
    • Unmet Clinical Needs in the Treatment of Patients with Thyroid Cancer
      Won Bae Kim, Min Ji Jeon, Won Gu Kim, Tae Yong Kim, Young Kee Shong
      Endocrinology and Metabolism.2020; 35(1): 14.     CrossRef
    • Regional nodal irradiation in pT1-2N1 breast cancer patients treated with breast-conserving surgery and whole breast irradiation
      Shin-Hyung Park, Jae-Chul Kim
      Radiation Oncology Journal.2020; 38(1): 44.     CrossRef
    • Targeted Therapy for Non-Small Cell Lung Cancer
      Jung Sun Kim, Eun Joo Kang
      The Korean Journal of Medicine.2020; 95(2): 78.     CrossRef
    • Prediction of Cancer Incidence and Mortality in Korea, 2020
      Kyu-Won Jung, Young-Joo Won, Seri Hong, Hyun-Joo Kong, Eun Sook Lee
      Cancer Research and Treatment.2020; 52(2): 351.     CrossRef
    • Body Mass Index and Risk of Gastric Cancer in Asian Adults: A Meta-Epidemiological Meta-Analysis of Population-Based Cohort Studies
      Jong-Myon Bae
      Cancer Research and Treatment.2020; 52(2): 369.     CrossRef
    • Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients
      Min Ae Cho, Soo Young Jeong, Insuk Sohn, Myeong-Seon Kim, Jun Hyeok Kang, E Sun Paik, Yoo-Young Lee, Chel Hun Choi
      Cancer Research and Treatment.2020; 52(2): 645.     CrossRef
    • Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017
      Seri Hong, Young-Joo Won, Young Ran Park, Kyu-Won Jung, Hyun-Joo Kong, Eun Sook Lee
      Cancer Research and Treatment.2020; 52(2): 335.     CrossRef
    • Diabetes, Metformin, and Lung Cancer: Retrospective Study of the Korean NHIS-HEALS Database
      Joungyoun Kim, Hyung-Jin Hyun, Eun-A. Choi, Ji Won Yoo, Scott Lee, Nicole Jeong, Jay J. Shen, Hyo-Sun You, Ye-seul Kim, Hee-Taik Kang
      Clinical Lung Cancer.2020; 21(6): e551.     CrossRef
    • Breast Cancer Statistics in Korea in 2017: Data from a Breast Cancer Registry
      Sang Yull Kang, Yoo Seok Kim, Zisun Kim, Hyun Yul Kim, Hee Jeong Kim, Sungmin Park, Soo Youn Bae, Kwang Hyun Yoon, Sae Byul Lee, Se Kyung Lee, Kyu-Won Jung, Jaihong Han, Hyun Jo Youn
      Journal of Breast Cancer.2020; 23(2): 115.     CrossRef
    • Association betweenALDH2Polymorphism and Gastric Cancer Risk in a Korean Population
      Chang Kyun Choi, Sun-Seog Kweon, Sang-Hee Cho, Hye-Yeon Kim, Min-Ho Shin
      Journal of Korean Medical Science.2020;[Epub]     CrossRef
    • Prognostic Role of Androgen Receptor Expression in Surgically Resected Early Breast Cancer Patients
      Yaewon Yang, Ahrum Min, Kyung-Hun Lee, Han Suk Ryu, Tae-Yong Kim, Go-un Woo, Koung Jin Suh, Dae-Won Lee, Han-Byoel Lee, Hyeong-Gon Moon, Wonshik Han, In Ae Park, Dong-Young Noh, Seock-Ah Im
      Journal of Breast Cancer.2020; 23(2): 182.     CrossRef
    • Evaluation of Efficacy and Safety of Nivolumab and Pembrolizumab in Elderly Cancer Patients
      Hye Sung Kim, HyoKeun Jeong, Mi Kyong Shim
      Korean Journal of Clinical Pharmacy.2020; 30(1): 11.     CrossRef
    • Association between Post-Diagnosis Particulate Matter Exposure among 5-Year Cancer Survivors and Cardiovascular Disease Risk in Three Metropolitan Areas from South Korea
      Seulggie Choi, Kyae Hyung Kim, Kyuwoong Kim, Jooyoung Chang, Sung Min Kim, Seong Rae Kim, Yoosun Cho, Gyeongsil Lee, Joung Sik Son, Sang Min Park
      International Journal of Environmental Research and Public Health.2020; 17(8): 2841.     CrossRef
    • Identification of Dietary Pattern Networks Associated with Gastric Cancer Using Gaussian Graphical Models: A Case-Control Study
      Madhawa Gunathilake, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Jeongseon Kim
      Cancers.2020; 12(4): 1044.     CrossRef
    • Risk of dementia in prostate cancer survivors: A nationwide cohort study in Korea
      Jihun Kang, Dong Wook Shin, Kyungdo Han, Sang Hyun Park, Won Gu Lee, Jung Eun Yoo, Seung-Hyo Woo, Jinsung Park
      Current Problems in Cancer.2020; 44(6): 100578.     CrossRef
    • Is gastric cancer becoming a rare disease? A global assessment of predicted incidence trends to 2035
      Melina Arnold, Jin Young Park, M Constanza Camargo, Nuno Lunet, David Forman, Isabelle Soerjomataram
      Gut.2020; 69(5): 823.     CrossRef
    • Design of a randomized controlled trial of a partnership-based, needs-tailored self-management support intervention for post-treatment breast cancer survivors
      Soo Hyun Kim, Yu Hyeon Choe, Ah Reum Han, Gwui Jeong Yeon, Gyeong Hee Lee, Bo Gyeong Lee, Young Up Cho, Seho Park, Moon Hee Lee
      BMC Cancer.2020;[Epub]     CrossRef
    • Tivantinib inhibits the VEGF signaling pathway and induces apoptosis in gastric cancer cells with c-MET or VEGFA amplification
      Bum Jun Kim, Yoo Jin Kim, Sung-Hwa Sohn, Bohyun Kim, Hee Jung Sul, Hyeong Su Kim, Dae Young Zang
      Investigational New Drugs.2020; 38(6): 1633.     CrossRef
    • Coronary Event Analysis in Breast Cancer Patients Who Received Breast-Conserving Surgery and Post-Operative Radiotherapy: a Korean Nationwide Cohort Study
      Soo-Yoon Sung, Jong Hoon Lee, Ki Hwa Yang, Yunye Seo, Mi Yeon Kang
      Journal of Breast Cancer.2020; 23(3): 291.     CrossRef
    • Validity of Breast Cancer Symptom Questionnaire and Its Relationship With Breast Ultrasonography in Young Female Night Workers
      Chang-Ho Chae
      Safety and Health at Work.2020; 11(3): 361.     CrossRef
    • Marital status and the prevalence of obesity in a Korean population
      Jeeyoo Lee, Aesun Shin, Sooyoung Cho, Ji-Yeob Choi, Daehee Kang, Jong-Koo Lee
      Obesity Research & Clinical Practice.2020; 14(3): 217.     CrossRef
    • The Survival Benefit of Combination Therapy With Mild Temperature Hyperthermia and an Herbal Prescription of Gun-Chil-Jung in 54 Cancer Patients Treated With Chemotherapy or Radiation Therapy: A Retrospective Study
      Hyeong Joon Jun, So-Jung Park, Hwi-Joong Kang, Ga-Young Lee, Namhun Lee, Ji Hye Park, Hwa-Seung Yoo
      Integrative Cancer Therapies.2020;[Epub]     CrossRef
    • Conducting and Reporting a Clinical Research Using Korean Healthcare Claims Database
      Seonji Kim, Myo-Song Kim, Seung-Hun You, Sun-Young Jung
      Korean Journal of Family Medicine.2020; 41(3): 146.     CrossRef
    • Resveratrol suppresses gastric cancer cell proliferation and survival through inhibition of PIM-1 kinase activity
      Sujin Kim, Wonki Kim, Do-Hee Kim, Jeong-Hoon Jang, Su-Jung Kim, Sin-Aye Park, Hyunggu Hahn, Byung Woo Han, Hye-Kyung Na, Kyung-Soo Chun, Bu Young Choi, Young-Joon Surh
      Archives of Biochemistry and Biophysics.2020; 689: 108413.     CrossRef
    • Metformin use reduced the risk of stomach cancer in diabetic patients in Korea: an analysis of Korean NHIS-HEALS database
      Joungyoun Kim, Hyeong-Jin Hyun, Eun-A. Choi, Yonghwan Kim, Yoon-Jong Bae, Hee-Taik Kang
      Gastric Cancer.2020; 23(6): 1075.     CrossRef
    • Optimized diagnosis ofHelicobacter pyloriand tailored eradication therapy for preventing gastric cancer: a proposal for SHAKE strategy
      Jun-Hyung Cho, So-Young Jin
      Expert Review of Gastroenterology & Hepatology.2020; 14(7): 553.     CrossRef
    • Differences in diagnosis, treatment, and survival rate of acute myeloid leukemia with or without disabilities: A national cohort study in the Republic of Korea
      Jihyun Kwon, So Young Kim, Kyoung Eun Yeob, Hye Sook Han, Ki Hyeong Lee, Dong Wook Shin, Yeon‐Yong Kim, Jong Heon Park, Jong Hyock Park, Ichiro Kawachi
      Cancer Medicine.2020; 9(15): 5335.     CrossRef
    • Associations between Physical Activity Level and Metabolic Risk Factors in Gynecological Cancer Survivors
      Sang-Hwa Lee, Jae-Weon Kim, Seok-Ju Seong, Yeon-Soo Kim
      The Korean Journal of Sports Medicine.2020; 38(2): 101.     CrossRef
    • Does increased body mass index lead to elevated prostate cancer risk? It depends on waist circumference
      Jin Bong Choi, Jun-Pyo Myong, Yunhee Lee, Inah Kim, Jung Ho Kim, Sung-Hoo Hong, U-Syn Ha
      BMC Cancer.2020;[Epub]     CrossRef
    • Highly prevalent BRAF V600E and low-frequency TERT promoter mutations underlie papillary thyroid carcinoma in Koreans
      Sue Youn Kim, Taeeun Kim, Kwangsoon Kim, Ja Seong Bae, Jeong Soo Kim, Chan Kwon Jung
      Journal of Pathology and Translational Medicine.2020; 54(4): 310.     CrossRef
    • Prognostic Factors for Premenopausal Women with Distant Metastatic Breast Cancer
      Jeungho Seung, Jai Min Ryu, Seok Jin Nam, Jeong Eon Lee, Jonghan Yu, Se Kyung Lee, Byung Joo Chae, Seok Won Kim
      Journal of Breast Disease.2020; 8(1): 1.     CrossRef
    • Comparing the Characteristics and Outcomes of Male and Female Breast Cancer Patients in Korea: Korea Central Cancer Registry
      Eun-Gyeong Lee, So-Youn Jung, Myong Cheol Lim, Jiwon Lim, Han-Sung Kang, Seeyoun Lee, Jai Hong Han, Heein Jo, Young-Joo Won, Eun Sook Lee
      Cancer Research and Treatment.2020; 52(3): 739.     CrossRef
    • Laparoscopic Surgery for Colorectal Cancer in Korea: Nationwide Data from 2013 to 2018
      Sun Jin Park, Kil Yeon Lee, Suk-Hwan Lee
      Cancer Research and Treatment.2020; 52(3): 938.     CrossRef
    • The prognostic role of preoperative serum albumin/globulin ratio in patients with non-metastatic renal cell carcinoma undergoing partial or radical nephrectomy
      Jae-Wook Chung, Dong Jin Park, So Young Chun, Seock Hwan Choi, Jun Nyung Lee, Bum Soo Kim, Hyun Tae Kim, Tae-Hwan Kim, Eun Sang Yoo, Seok-Soo Byun, Eu Chang Hwang, Seok Ho Kang, Sung-Hoo Hong, Jinsoo Chung, Cheol Kwak, Yong- June Kim, Yun-Sok Ha, Tae Gyun
      Scientific Reports.2020;[Epub]     CrossRef
    • Acceptance on colorectal cancer screening upper age limit in South Korea
      Xuan Quy Luu, Kyeongmin Lee, Yun Yoeng Lee, Mina Suh, Yeol Kim, Kui Son Choi
      World Journal of Gastroenterology.2020; 26(27): 3959.     CrossRef
    • Acceptance on colorectal cancer screening upper age limit in South Korea
      Xuan Quy Luu, Kyeongmin Lee, Yun Yoeng Lee, Mina Suh, Yeol Kim, Kui Son Choi
      World Journal of Gastroenterology.2020; 26(27): 3963.     CrossRef
    • Global Burden of 5 Major Types of Gastrointestinal Cancer
      Melina Arnold, Christian C. Abnet, Rachel E. Neale, Jerome Vignat, Edward L. Giovannucci, Katherine A. McGlynn, Freddie Bray
      Gastroenterology.2020; 159(1): 335.     CrossRef
    • Risk of fracture incidence in prostate cancer survivors: a nationwide cohort study in South Korea
      Hyun Bin Shin, Hyun Sik Park, Jung Eun Yoo, Kyungdo Han, Sang Hyun Park, Dong Wook Shin, Jinsung Park
      Archives of Osteoporosis.2020;[Epub]     CrossRef
    • Anticancer Effect of Mountain Ginseng on Human Breast Cancer: Comparison with Farm‐Cultivated Ginseng
      Jungeun Kim, Jae-Myung Yoo, Jin Soo Kim, Sun-Gun Kim, Jong Eel Park, Young Mi Seok, Jun-Ho Son, Hyo Jung Kim, Keturah R. Faurot
      Evidence-Based Complementary and Alternative Medicine.2020;[Epub]     CrossRef
    • Laparoscopic complete mesocolic excision with D3 lymph node dissection for right colon cancer in elderly patients
      Duk Yeon Hwang, Gyeo Ra Lee, Ji Hoon Kim, Yoon Suk Lee
      Scientific Reports.2020;[Epub]     CrossRef
    • Multi-Grain Rice Diet Decreases Risk of Breast Cancer in Korean Women: Results from the Health Examinees Study
      Woo-Kyoung Shin, Hwi-Won Lee, Aesun Shin, Jong-koo Lee, Sang-Ah Lee, Jung Eun Lee, Daehee Kang
      Nutrients.2020; 12(8): 2273.     CrossRef
    • Updates of Chemotherapy and Radiotherapy for Pancreatic Cancer
      Min Je Sung, Seungmin Bang
      The Korean Journal of Pancreas and Biliary Tract.2020; 25(2): 72.     CrossRef
    • Anthocyanins Isolated from Vitis coignetiae Pulliat Enhances Cisplatin Sensitivity in MCF-7 Human Breast Cancer Cells through Inhibition of Akt and NF-κB Activation
      Anjugam Paramanantham, Min Jeong Kim, Eun Joo Jung, Hye Jung Kim, Seong-Hwan Chang, Jin-Myung Jung, Soon Chan Hong, Sung Chul Shin, Gon Sup Kim, Won Sup Lee
      Molecules.2020; 25(16): 3623.     CrossRef
    • A return-to-work intervention protocol directed at cancer patients (self-assessment, tailored information & lifestyle management for returning to work among cancer patients, START): A multi-center, randomized controlled trial
      Ka Ryeong Bae, Danbee Kang, Jae Yoon Yi, Yeojin Ahn, Im-Ryung Kim, Sun-Seog Kweon, Jin Seok Ahn, Seok Jin Nam, Young Mog Shim, Mison Chun, Jaesung Heo, Juhee Cho
      Contemporary Clinical Trials Communications.2020; 19: 100633.     CrossRef
    • The Burden of Cervical Cancer in Korea: A Population-Based Study
      Jinhee Kim, Donghwan Lee, Kyung-Bok Son, SeungJin Bae
      International Journal of Environmental Research and Public Health.2020; 17(17): 6308.     CrossRef
    • TNF genetic polymorphism (rs1799964) may modify the effect of the dietary inflammatory index on gastric cancer in a case–control study
      Jeeeun Kim, Jeonghee Lee, Il Ju Choi, Young-Il Kim, Joohon Sung, Jeongseon Kim
      Scientific Reports.2020;[Epub]     CrossRef
    • PI3K p110α Blockade Enhances Anti-Tumor Efficacy of Abemaciclib in Human Colorectal Cancer Cells
      Hyun Jung Lee, Kui-Jin Kim, Ji Hea Sung, Milang Nam, Koung Jin Suh, Ji-Won Kim, Se Hyun Kim, Jin Won Kim, Yu Jung Kim, Keun-Wook Lee, Jong Seok Lee, Jee Hyun Kim
      Cancers.2020; 12(9): 2500.     CrossRef
    • Qualitative Study of Compliance with Nutritional Management in Colorectal Cancer Patient Undergoing Chemotherapy
      Heejung Park, Hyonson Kil, Wookyoun Cho
      Korean Journal of Community Nutrition.2020; 25(4): 303.     CrossRef
    • Immune landscape and biomarkers for immuno-oncology in colorectal cancers
      Jeong Mo Bae, Seung-Yeon Yoo, Jung Ho Kim, Gyeong Hoon Kang
      Journal of Pathology and Translational Medicine.2020; 54(5): 351.     CrossRef
    • Docetaxel rechallenge in metastatic castration-resistant prostate cancer: A retrospective, single-center study
      Seonggyu Byeon, Hyera Kim, Jinchul Kim, Minsuk Kwon, Joon Young Hur, Hwang Gyun Jeon, Seong Soo Jeon, Hyun Moo Lee, Se Hoon Park
      Investigative and Clinical Urology.2020; 61(6): 588.     CrossRef
    • Occupational disparities in survival in Korean women with cancer: a nationwide registry linkage study
      Hye-Eun Lee, Eun-A KIM, Masayoshi Zaitsu, Ichiro Kawachi
      BMJ Open.2020; 10(9): e039259.     CrossRef
    • Intratumoral CD103‐positive tumour‐infiltrating lymphocytes are associated with favourable prognosis in patients with triple‐negative breast cancer
      Min H Park, Sun Y Kwon, Jung E Choi, Gyungyub Gong, Young K Bae
      Histopathology.2020; 77(4): 560.     CrossRef
    • Comparison of Fentanyl versus Meperidine in Combination with Midazolam for Sedative Colonoscopy in Korea
      Gwan Woo Hong, Jun Kyu Lee, Jung Hyeon Lee, Ji Hun Bong, Sung Hun Choi, Hyeki Cho, Ji Hyung Nam, Dong Kee Jang, Hyoun Woo Kang, Jae Hak Kim, Yun Jeong Lim, Moon Soo Koh, Jin Ho Lee
      Clinical Endoscopy.2020; 53(5): 562.     CrossRef
    • Factors Associated with Health Behaviors in Thyroid Cancer Survivors
      Junghyun Yoon, Boyoung Park
      Journal of Cancer Prevention.2020; 25(3): 173.     CrossRef
    • Heterogenous Effect of Risk Factors on Breast Cancer across the Breast Density Categories in a Korean Screening Population
      Boyoung Park, Se-Eun Lim, HyoJin Ahn, Junghyun Yoon, Yun Su Choi
      Cancers.2020; 12(6): 1391.     CrossRef
    • iRGD Peptide as a Tumor-Penetrating Enhancer for Tumor-Targeted Drug Delivery
      Sujin Kang, Sooyeun Lee, Soyeun Park
      Polymers.2020; 12(9): 1906.     CrossRef
    • Prognostic Implications of CD10 and CD15 Expression in Papillary Thyroid Carcinoma
      Eun Ji Oh, Andrey Bychkov, Haejin Cho, Tae-Min Kim, Ja Seong Bae, Dong-Jun Lim, Chan Kwon Jung
      Cancers.2020; 12(6): 1413.     CrossRef
    • Long-term Survival of a Patient with a Large Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombosis and Spontaneous Tumor Rupture
      Hyung-Woo Lee, Gi-Ae Kim, Chi Hyuk Oh, Jae-Jun Shim, Byung-Ho Kim
      Journal of Liver Cancer.2020; 20(2): 148.     CrossRef
    • 17β-Estradiol strongly inhibits azoxymethane/dextran sulfate sodium-induced colorectal cancer development in Nrf2 knockout male mice
      Chin-Hee Song, Nayoung Kim, Ryoung Hee Nam, Soo In Choi, Joo Hee Son, Jeong Eun Yu, Eun Shin, Ha-Na Lee, Do-Hee Kim, Young-Joon Surh
      Biochemical Pharmacology.2020; 182: 114279.     CrossRef
    • Correlation between Gleason score distribution and Prostate Health Index in patients with prostate-specific antigen values of 2.5–10 ng/mL
      Joongwon Choi, Minyong Kang, Hyun Hwan Sung, Hwang Gyun Jeon, Byong Chang Jeong, Seong Il Seo, Seong Soo Jeon, Hyun Moo Lee
      Investigative and Clinical Urology.2020; 61(6): 582.     CrossRef
    • Application of Epidemiological Geographic Information System: An Open-Source Spatial Analysis Tool Based on the OMOP Common Data Model
      Jaehyeong Cho, Seng Chan You, Seongwon Lee, DongSu Park, Bumhee Park, George Hripcsak, Rae Woong Park
      International Journal of Environmental Research and Public Health.2020; 17(21): 7824.     CrossRef
    • Sex-Biased Molecular Signature for Overall Survival of Liver Cancer Patients
      Sun Young Kim, Hye Kyung Song, Suk Kyeong Lee, Sang Geon Kim, Hyun Goo Woo, Jieun Yang, Hyun-Jin Noh, You-Sun Kim, Aree Moon
      Biomolecules & Therapeutics.2020; 28(6): 491.     CrossRef
    • Association of long noncoding RNA MALAT1 polymorphisms with gastric cancer risk in Korean individuals
      Jang Hee Hong, Eun‐Heui Jin, In Ae Chang, Hyojin Kang, Sang‐Il Lee, Jae Kyu Sung
      Molecular Genetics & Genomic Medicine.2020;[Epub]     CrossRef
    • Clinical Characteristics and Treatment Outcomes in Children, Adolescents, and Young-adults with Hodgkin's Lymphoma: a KPHOG Lymphoma Working-party, Multicenter, Retrospective Study
      Jae Min Lee, Jung Yoon Choi, Kyung Taek Hong, Hyoung Jin Kang, Hee Young Shin, Hee Jo Baek, Hoon Kook, Seongkoo Kim, Jae Wook Lee, Nack-Gyun Chung, Bin Cho, Seok-Goo Cho, Kyung Mi Park, Eu Jeen Yang, Young Tak Lim, Jin Kyung Suh, Sung Han Kang, Hyery Kim,
      Journal of Korean Medical Science.2020;[Epub]     CrossRef
    • Relationships of Symptom Groups and Functioning Domains in Patients with Advanced-Stage Non-Small Cell Lung Cancer Undergoing Treatment: A Cross-Sectional Study
      Myung Kyung Lee
      Healthcare.2020; 9(1): 28.     CrossRef
    • A Phase II Trial of Tipifarnib for Patients with Previously Treated, Metastatic Urothelial Carcinoma HarboringHRASMutations
      Hye Won Lee, Jason K. Sa, Antonio Gualberto, Catherine Scholz, Hyun Hwan Sung, Byong Chang Jeong, Han Yong Choi, Ghee Young Kwon, Se Hoon Park
      Clinical Cancer Research.2020; 26(19): 5113.     CrossRef
    • Smoking status before and after colorectal cancer diagnosis and mortality in Korean men: A population‐based cohort study
      Doeun Jang, Sunho Choe, Ji Won Park, Seung‐Yong Jeong, Aesun Shin
      Cancer Medicine.2020; 9(24): 9641.     CrossRef
    • Association Between Angiotensin II Receptor Blockers and the Risk of Lung Cancer Among Patients With Hypertension From the Korean National Health Insurance Service-National Health Screening Cohort
      Sungji Moon, Hae-Young Lee, Jieun Jang, Sue K. Park
      Journal of Preventive Medicine and Public Health.2020; 53(6): 476.     CrossRef
    • Prognosis of Patients with Colorectal Cancer with Diabetes According to Medication Adherence: A Population-Based Cohort Study
      Sunho Choe, Joonki Lee, Ji Won Park, Seung-Yong Jeong, Young Min Cho, Byung-Joo Park, Aesun Shin
      Cancer Epidemiology, Biomarkers & Prevention.2020; 29(6): 1120.     CrossRef
    • Harmonic versus LigaSure for Flap Creation in Bilateral Axillary Breast Approach Thyroid Surgery
      Han Byul Ryu, Jong-hyuk Ahn, Jae Hwan Kim, Seong Woon Choi, Yun Suk Choi, Jin Wook Yi
      Journal of Endocrine Surgery.2020; 20(4): 69.     CrossRef
    • Long-Term Glucocorticoid Use and Cancer Risk: A Population-Based Cohort Study in South Korea
      Tak Kyu Oh, In-Ae Song
      Cancer Prevention Research.2020; 13(12): 1017.     CrossRef
    • Preoperative Neutrophil to Lymphocyte Ratio and Albumin Level as Predictors for Postoperative Complication in Patients with Colorectal Cancer
      Kyung Pil Kang, Young Hun Kim, Kyung Jong Kim
      Surgical Metabolism and Nutrition.2020; 11(2): 66.     CrossRef
    • The therapeutic effects of Physalis alkekengi hydroalcoholic extract on estrogen receptor-positive breast cancer mice model: possible role of autophagy in this therapeutic response
      Zahra Zare, Maryam Teimouri
      Journal of Shahrekord University of Medical Sciences.2020; 22(4): 181.     CrossRef
    • PROMISE CLIP Project: A Retrospective, Multicenter Study for Prostate Cancer that Integrates Clinical, Imaging and Pathology Data
      Jihwan Park, Mi Jung Rho, Yong Hyun Park, Chan Kwon Jung, Yosep Chong, Choung-Soo Kim, Heounjeong Go, Seong Soo Jeon, Minyong Kang, Hak Jong Lee, Sung Il Hwang, Ji Youl Lee
      Applied Sciences.2019; 9(15): 2982.     CrossRef
    • Comparative effectiveness of palliative chemotherapy versus neoadjuvant chemotherapy followed by radical cystectomy versus cystectomy followed by adjuvant chemotherapy versus cystectomy for regional node‐positive bladder cancer: A retrospective analysis:
      Woo Kyun Bae, Hyo Jin Lee, Se Hoon Park, Jung Hoon Kim, Hee Jun Kim, Chi Hoon Maeng, Inkeun Park, Byeong Seok Sohn, Jung A. Kim, Kyung Hee Lee, Do Hyoung Lim, Hyun Chang, Sung Min Kim, Ho Young Kim, Hunho Song, Seungtaek Lim, Jae Ho Byun, Hyun Ae Jung
      Cancer Medicine.2019; 8(12): 5431.     CrossRef
    • Early-onset Colorectal Cancer
      Mo Ah Jeong, Hyoun Woo Kang
      The Korean Journal of Gastroenterology.2019; 74(1): 4.     CrossRef
    • Colorectal cancer epidemiology in Korea
      Aesun Shin, Doeun Jang, Sunho Choe, Young-Joo Won, Kyu-Won Jung, Ji Won Park, Seung-Yong Jeong
      Journal of the Korean Medical Association.2019; 62(8): 407.     CrossRef
    • National Lung Cancer Screening in Korea: Introduction and Imaging Quality Control
      Hyae Young Kim
      Journal of the Korean Society of Radiology.2019; 80(5): 826.     CrossRef
    • Adherence to the American Cancer Society Guidelines for Cancer Survivors and Health-Related Quality of Life among Breast Cancer Survivors
      Dahye Koh, Sihan Song, Sang-Eun Moon, So-Youn Jung, Eun Sook Lee, Zisun Kim, Hyun Jo Youn, Jihyoung Cho, Young Bum Yoo, Se Kyung Lee, Jeong Eon Lee, Seok Jin Nam, Jung Eun Lee
      Nutrients.2019; 11(12): 2924.     CrossRef
    • Prognostic significance of lymphovascular invasion in patients with prostate cancer treated with postoperative radiotherapy
      Jae-Uk Jeong, Taek-Keun Nam, Ju-Young Song, Mee Sun Yoon, Sung-Ja Ahn, Woong-Ki Chung, Ick Joon Cho, Yong-Hyub Kim, Shin Haeng Cho, Seung Il Jung, Dong Deuk Kwon
      Radiation Oncology Journal.2019; 37(3): 215.     CrossRef
    • Second Primary Cancer after Treating Gastrointestinal Cancer
      Jeong Youp Park
      The Korean Journal of Gastroenterology.2019; 74(4): 193.     CrossRef
    • Surgical outcomes and prognostic factors of gastric cancer surgery in octogenarians
      Ik Beom Shin, Sung Jin Oh, Byoung Jo Suh
      Korean Journal of Clinical Oncology.2019; 15(2): 112.     CrossRef
    • Initial Experience of BABA Robotic Thyroidectomy Using the Da Vinci Xi System in Incheon, Korea
      Hye Jeong Yoon, Jong-hyuk Ahn, Jae Hwan Kim, Jin Wook Yi, Min Hee Hur
      Journal of Endocrine Surgery.2019; 19(3): 59.     CrossRef
    • Electro-Acupuncture Alleviates Cisplatin-Induced Anorexia in Rats by Modulating Ghrelin and Monoamine Neurotransmitters
      Ji Yun Baek, Tuy An Trinh, Wonsang Huh, Ji Hoon Song, Hyun Young Kim, Juhee Lim, Jinhee Kim, Hyun Jin Choi, Tae-Hun Kim, Ki Sung Kang
      Biomolecules.2019; 9(10): 624.     CrossRef
    • Changes in the Treatment Strategies forHelicobacter pyloriInfection in Children and Adolescents in Korea
      Jin-Su Jun, Ji-Hyun Seo, Ji-Sook Park, Kwang-Ho Rhee, Hee-Shang Youn
      Pediatric Gastroenterology, Hepatology & Nutrition.2019; 22(5): 417.     CrossRef
    • Local ablative radiotherapy for oligometastatic non-small cell lung cancer
      Yang-Gun Suh, Jaeho Cho
      Radiation Oncology Journal.2019; 37(3): 149.     CrossRef
    • Clinicopathological Characteristics of Asymptomatic Young Patients with Gastric Cancer Detected during a Health Checkup
      Hyoung Ho Moon, Hyoun Woo Kang, Seong-Joon Koh, Ji Won Kim, Cheol Min Shin
      The Korean Journal of Gastroenterology.2019; 74(5): 281.     CrossRef
    • History of Diabetes Mellitus and Risk of Prostate Cancer: A Meta-Epidemiological Study of Population-Based Cohort Studies in East Asian Men
      Jong-Myon Bae
      The Korean Journal of Urological Oncology.2019; 17(3): 119.     CrossRef
    • Current status of proton therapy techniques for lung cancer
      Youngyih Han
      Radiation Oncology Journal.2019; 37(4): 232.     CrossRef
    • Notch1 in Tumor Microvascular Endothelial Cells and Tumoral miR-34a as Prognostic Markers in Locally Advanced Triple-Negative Breast Cancer
      Dongmin Kim, Jieun Lee, Jun Kang, Sung Hun Kim, Tae-Kyung Yoo, Sooeun Oh, Ahwon Lee
      Journal of Breast Cancer.2019; 22(4): 562.     CrossRef
    • Association of N6-methyladenosine with viruses and related diseases
      Fang Wu, Wenzhao Cheng, Feiyuan Zhao, Mingqing Tang, Yong Diao, Ruian Xu
      Virology Journal.2019;[Epub]     CrossRef
    • Does Holding Back Cancer-Related Concern Affect Couples' Marital Relationship and Quality of Life of Patients with Lung Cancer? An Actor–Partner Interdependence Mediation Modeling Approach
      Soonyoung Oh, Eunjung Ryu
      Asian Nursing Research.2019; 13(4): 277.     CrossRef
    • Cancer Survivorship in Primary Care
      Jihun Kang, Eun Ju Park, Jungkwon Lee
      Korean Journal of Family Medicine.2019; 40(6): 353.     CrossRef
    • Performance Evaluation of the Total ProstateSpecific Antigen (PSA), Free PSA, and [–2]proPSA Assay for Calculation of the Prostate Health Index Using the UniCel DxI 800 Analyzer
      Won-Kyu Choi, Hyun-Ki Kim, Woochang Lee, Sail Chun, Won-Ki Min
      Journal of Laboratory Medicine and Quality Assurance.2019; 41(4): 207.     CrossRef
    • Optimal treatment of breast cancer in women older than 75 years: a Korea Breast Cancer Registry analysis
      Ye Won Jeon, Sun Hyong You, Jong Eun Lee, Hyun Jo Youn, Woosung Lim, Jai Hong Han, Chan Heun Park, Yong Seok Kim
      Breast Cancer Research and Treatment.2019; 178(3): 693.     CrossRef
    • Differentiation of gallbladder adenomyomatosis from early-stage gallbladder cancer before surgery
      Jisum Moon, Yong Chan Shin, Tae-Gil Heo, Pyong Wha Choi, Jae Il Kim, Sung Won Jung, Heungman Jun, Sung Min Jung, Eunhae Um
      Annals of Hepato-Biliary-Pancreatic Surgery.2019; 23(4): 334.     CrossRef
    • Association between hand grip strength and impaired health-related quality of life in Korean cancer survivors: a cross-sectional study
      Jeongki Paek, Yoon Ji Choi
      BMJ Open.2019; 9(9): e030938.     CrossRef
    • Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag
      Anshu Rastogi, Amina Ali, Shyh-Han Tan, Sreedatta Banerjee, Yongmei Chen, Jennifer Cullen, Charles P. Xavier, Ahmed A. Mohamed, Lakshmi Ravindranath, Jigisha Srivastav, Denise Young, Isabell A. Sesterhenn, Jacob Kagan, Sudhir Srivastava, David G. McLeod,
      Genes & Cancer.2017; 7(11-12): 394.     CrossRef
    • The importance of tissue confirmation of metastatic disease in patients with breast cancer: lesson from a brain metastasis case
      Jingxian Ding, Pinghua Hu, Jun Chen, Xiaobo Wu, Yali Cao
      Oncoscience.2016; 3(9-10): 268.     CrossRef

    • PubReader PubReader
    • ePub LinkePub Link
    • Cite
      CITE
      export Copy Download
      Close
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016
      Cancer Res Treat. 2019;51(2):417-430.   Published online March 18, 2019
      Close
    • XML DownloadXML Download
    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016
    Image Image Image Image Image Image
    Fig. 1. Annual age-standardized cancer incidence and death rates by sex for all sites from 1983 to 2016 in Korea. Age standardization was based on the Segi’s world standard population.
    Fig. 2. Trends in age-standardized incidences of selected cancers by sex from 1999 to 2016 in Korea. (A) Men. (B) Women. Age standardization was based on the Segi’s world standard population.
    Fig. 3. Annual age-standardized cancer mortalities of selected cancers by sex from 1983 to 2016 in Korea. (A) Men. (B) Women. Age standardization was based on the Segi’s world standard population.
    Fig. 4. Age-specific incidence rates of common cancers for 2016 in Korea. (A) Men. (B) Women.
    Fig. 5. Trends in relative survival by year of diagnosis from 1999 to 2016. (A) All sites for both sexes. (B) All sites except thyroid cancer for both sexes.
    Fig. 6. Prevalence of common cancer sites by time period after cancer diagnosis. Prevalent cases were defined as the number of cancer patients alive on January 1, 2017 among all cancer patients diagnosed between 1999 and 2016.
    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016
    Site/Type New cases
    Deaths
    Prevalent casesa)
    Both sexes Men Women Both sexes Men Women Both sexes Men Women
    All sites 229,180 120,068 109,112 78,194 48,208 29,986 1,739,951 764,103 975,848
    Lip, oral cavity, and pharynx 3,543 2,527 1,016 1,203 909 294 23,639 15,847 7,792
    Esophagus 2,499 2,245 254 1,524 1,379 145 9,777 8,780 997
    Stomach 30,504 20,509 9,995 8,264 5,318 2,946 273,701 181,234 92,467
    Colon and rectum 28,127 16,672 11,455 8,358 4,659 3,699 236,431 140,852 95,579
    Liver 15,771 11,774 3,997 11,001 8,044 2,957 64,864 48,666 16,198
    Gallbladderb) 6,685 3,490 3,195 4,408 2,248 2,160 21,011 10,776 10,235
    Pancreas 6,655 3,384 3,271 5,614 2,901 2,713 10,595 5,502 5,093
    Larynx 1,167 1,101 66 334 310 24 10,532 9,914 618
    Lung 25,780 17,790 7,990 17,963 13,324 4,639 76,544 47,438 29,106
    Breast 21,839 92 21,747 2,472 16 2,456 198,006 743 197,263
    Cervix uteri 3,566 - 3,566 897 - 897 52,758 - 52,758
    Corpus uteri 2,771 - 2,771 313 - 313 23,135 - 23,135
    Ovary 2,630 - 2,630 1,204 - 1,204 19,509 - 19,509
    Prostate 11,800 11,800 - 1,745 1,745 - 77,635 77,635 -
    Testis 288 288 - 14 14 - 3,204 3,204 -
    Kidney 5,043 3,410 1,633 1,032 724 308 38,836 26,161 12,675
    Bladder 4,361 3,488 873 1,389 1,029 360 33,543 27,347 6,196
    Brain and CNS 2,015 1,104 911 1,327 720 607 11,116 5,734 5,382
    Thyroid 26,051 5,538 20,513 346 104 242 379,946 65,336 314,610
    Hodgkin lymphoma 312 202 110 51 33 18 2,807 1,770 1,037
    Non-Hodgkin lymphoma 4,766 2,766 2,000 1,820 1,068 752 30,093 17,130 12,963
    Multiple myeloma 1,535 837 698 1,010 527 483 5,798 3,050 2,748
    Leukemia 3,416 1,991 1,425 1,842 1,025 817 20,751 11,553 9,198
    Other and ill-defined 18,056 9,060 8,996 4,063 2,111 1,952 115,720 55,431 60,289
    Site/Type Crude incidence rate per 100,000
    Age-standardized incidence rate per 100,000a)
    Both sexes Men Women Both sexes Men Women
    All sites 448.4 470.3 426.5 269.0 298.0 254.6
    Lip, oral cavity, and pharynx 6.9 9.9 4.0 4.2 6.4 2.3
    Esophagus 4.9 8.8 1.0 2.7 5.4 0.5
    Stomach 59.7 80.3 39.1 34.0 49.6 20.5
    Colon and rectum 55.0 65.3 44.8 30.7 40.4 22.4
    Liver 30.9 46.1 15.6 17.6 28.5 7.8
    Gallbladderb) 13.1 13.7 12.5 6.7 8.3 5.5
    Pancreas 13.0 13.3 12.8 7.0 8.1 6.0
    Larynx 2.3 4.3 0.3 1.3 2.6 0.1
    Lung 50.4 69.7 31.2 27.1 42.3 15.4
    Breast 42.7 0.4 85.0 27.7 0.2 54.9
    Cervix uteri 7.0 0.0 13.9 4.6 - 9.1
    Corpus uteri 5.4 0.0 10.8 3.4 - 6.8
    Ovary 5.1 0.0 10.3 3.4 - 6.7
    Prostate 23.1 46.2 0.0 12.5 28.2 -
    Testis 0.6 1.1 0.0 0.6 1.1 -
    Kidney 9.9 13.4 6.4 6.1 8.7 3.8
    Bladder 8.5 13.7 3.4 4.5 8.4 1.6
    Brain and CNS 3.9 4.3 3.6 3.1 3.5 2.7
    Thyroid 51.0 21.7 80.2 36.6 15.6 58.1
    Hodgkin lymphoma 0.6 0.8 0.4 0.5 0.6 0.4
    Non-Hodgkin lymphoma 9.3 10.8 7.8 6.2 7.7 4.8
    Multiple myeloma 3.0 3.3 2.7 1.7 2.0 1.4
    Leukemia 6.7 7.8 5.6 5.6 6.6 4.7
    Other and ill-defined 35.3 35.5 35.2 21.2 23.7 19.1
    Rank Cause of death No. of deaths (%) Age-standardized death rate per 100,000a)
    All causes 280,827 (100) 280.8
    1 Cancer 78,194 (27.8) 79.8
    2 Heart disease 9,807 (3.5) 9.0
    3 Cerebrovascular disease 5,416 (1.9) 4.6
    4 Pneumonia 29,735 (10.6) 27.8
    5 Intentional self-harm (suicide) 23,415 (8.3) 21.4
    6 Diabetes mellitus 16,476 (5.9) 14.3
    7 Chronic lower respiratory diseases 6,992 (2.5) 6.0
    8 Disease of liver 6,798 (2.4) 7.7
    9 Transport accidents 5,150 (1.8) 6.8
    10 Hypertensive diseases 13,092 (4.7) 17.7
    Others 85,752 (30.5) 85.9
    Site/Type Crude mortality rate per 100,000
    Age-standardized mortality rate per 100,000a)
    Both sexes Men Women Both sexes Men Women
    All sites 153.0 188.8 117.2 79.8 115.5 53.6
    Lip, oral cavity, and pharynx 2.4 3.6 1.1 1.3 2.2 0.5
    Esophagus 3.0 5.4 0.6 1.6 3.2 0.2
    Stomach 16.2 20.8 11.5 8.3 12.7 5.0
    Colon and rectum 16.4 18.3 14.5 8.2 11.1 5.9
    Liver 21.5 31.5 11.6 11.7 19.2 5.2
    Gallbladderb) 8.6 8.8 8.4 4.2 5.3 3.4
    Pancreas 11.0 11.4 10.6 5.7 7.0 4.6
    Larynx 0.7 1.2 0.1 0.3 0.8 0.0
    Lung 35.1 52.2 18.1 17.6 31.2 7.7
    Breast 4.8 0.1 9.6 2.9 0.0 5.5
    Cervix uteri 1.8 0.0 3.5 1.0 - 1.8
    Corpus uteri 0.6 0.0 1.2 0.4 - 0.7
    Ovary 2.4 0.0 4.7 1.3 - 2.5
    Prostate 3.4 6.8 0.0 1.5 4.2 -
    Testis 0.0 0.1 0.0 0.0 0.0 -
    Kidney 2.0 2.8 1.2 1.1 1.8 0.5
    Bladder 2.7 4.0 1.4 1.3 2.5 0.5
    Brain and CNS 2.6 2.8 2.4 1.7 2.0 1.4
    Thyroid 0.7 0.4 0.9 0.3 0.2 0.4
    Hodgkin lymphoma 0.1 0.1 0.1 0.1 0.1 0.0
    Non-Hodgkin lymphoma 3.6 4.2 2.9 1.9 2.6 1.4
    Multiple myeloma 2.0 2.1 1.9 1.0 1.2 0.9
    Leukemia 3.6 4.0 3.2 2.3 2.8 1.9
    Other and ill-defined 7.9 8.3 7.6 4.3 5.3 3.5
    Site/Type Both sexes
    Men
    Women
    1999 2016 Trend 1
    Trend 2
    1999 2016 Trend 1
    Trend 2
    1999 2016 Trend 1
    Trend 2
    Year APC Year APC Year APC Year APC Year APC Year APC
    All sites 210.5 269.0 1999-2011 3.6a) 2011-2016 –3.1a) 285.0 298.0 1999-2011 1.7a) 2011-2016 –3.0a) 161.1 254.6 1999-2011 5.8a) 2011-2016 –3.5a)
    Lip, oral cavity, and pharynx 3.6 4.2 1999-2016 0.6a) - - 6.1 6.4 1999-2016 –0.1 - - 1.6 2.3 1999-2016 1.5a) - -
    Esophagus 4.1 2.7 1999-2016 –2.2a) - - 8.8 5.4 1999-2016 –2.7a) - - 0.6 0.5 1999-2016 –1.5a) - -
    Stomach 43.6 34.0 1999-2011 –0.2 2011-2016 –4.9a) 66.2 49.6 1999-2011 –0.4a) 2011-2016 –5.4a) 26.7 20.5 1999-2011 –0.4 2011-2016 –4.5a)
    Colon and rectum 20.4 30.7 1999-2010 6.0a) 2010-2016 –4.5a) 26.2 40.4 1999-2010 6.5a) 2010-2016 –5.0a) 16.4 22.4 1999-2010 4.9a) 2010-2016 –3.9a)
    Liver 27.9 17.6 1999-2010 –1.7a) 2010-2016 –4.4a) 46.8 28.5 1999-2009 –1.9a) 2009-2016 –4.1a) 12.3 7.8 1999-2010 –1.5a) 2010-2016 –4.8a)
    Gallbladderb) 6.5 6.7 1999-2004 1.5 2004-2016 –0.3 8.1 8.3 1999-2016 0.1 - - 5.4 5.5 1999-2003 2.4 2003-2016 –0.5a)
    Pancreas 5.6 7.0 1999-2016 1.4a) - - 7.8 8.1 1999-2016 0.5a) - - 4.0 6.0 1999-2016 2.3a) - -
    Larynx 2.3 1.3 1999-2016 –3.6a) - - 4.9 2.6 1999-2016 –3.8a) - - 0.4 0.1 1999-2007 –9.0a) 2007-2016 –4.1a)
    Lung 28.5 27.1 1999-2011 0.1 2011-2016 –1.4a) 51.4 42.3 1999-2005 –0.1 2005-2016 –1.6a) 12.4 15.4 1999-2011 2.0a) 2011-2016 –0.1
    Breast 10.7 27.7 1999-2005 7.6a) 2005-2016 4.5a) 0.2 0.2 1999-2016 –0.8 20.9 54.9 1999-2005 7.8a) 2005-2016 4.6a)
    Cervix uteri 8.5 4.6 1999-2016 –3.8a) - - - - - - - - 16.3 9.1 1999-2016 –3.6a) - -
    Corpus uteri 1.4 3.4 1999-2003 8.8a) 2003-2016 4.6a) - - - - - - 2.8 6.8 1999-2003 9.1a) 2003-2016 4.7a)
    Ovary 2.7 3.4 1999-2016 1.6a) - - - - - - - - 5.0 6.7 1999-2016 1.9a) - -
    Prostate 3.1 12.5 1999-2009 15.1a) 2009-2016 1.0 8.4 28.2 1999-2009 13.5a) 2009-2016 0.2 - - - - - -
    Testis 0.3 0.6 1999-2016 4.9a) - - 0.6 1.1 1999-2016 4.7a) - - - - - - - -
    Kidney 3.0 6.1 1999-2009 6.6a) 2009-2016 1.7a) 4.5 8.7 1999-2010 6.0a) 2010-2016 0.8 1.7 3.8 1999-2008 6.9a) 2008-2016 2.2a)
    Bladder 4.6 4.5 1999-2004 2.2a) 2004-2016 –1.2a) 9.0 8.4 1999-2004 2.0a) 2004-2016 –1.5a) 1.6 1.6 1999-2003 2.2 2003-2016 –1.4a)
    Brain and CNS 2.9 3.1 1999-2016 0.2 - - 3.2 3.5 1999-2016 0.3 - - 2.6 2.7 1999-2016 0.1 - -
    Thyroid 6.3 36.6 1999-2011 22.6a) 2011-2016 –12.6a) 2.1 15.6 1999-2012 22.5a) 2012-2016 –14.0a) 10.4 58.1 1999-2011 22.3a) 2011-2016 –13.5a)
    Hodgkin lymphoma 0.2 0.5 1999-2016 4.0a) - - 0.4 0.6 1999-2016 3.2a) - - 0.1 0.4 1999-2016 5.1a) - -
    Non-Hodgkin lymphoma 4.3 6.2 1999-2016 2.4a) - - 5.6 7.7 1999-2016 2.0a) - - 3.3 4.8 1999-2016 2.6a) - -
    Multiple myeloma 1.0 1.7 1999-2012 3.7a) 2012-2016 0.8 1.2 2.0 1999-2012 3.5a) 2012-2016 0.5 0.8 1.4 1999-2006 6.1a) 2006-2016 2.2a)
    Leukemia 4.7 5.6 1999-2016 1.0a) - - 5.5 6.6 1999-2016 1.1a) - - 3.9 4.7 1999-2016 0.8a) - -
    Other and ill-defined 14.4 21.2 1999-2007 3.6a) 2007-2016 1.7a) 18.1 23.7 1999-2016 1.9a) - - 11.9 19.1 1999-2008 4.2a) 2008-2016 1.7a)
    Site/Type Both sexes
    Men
    Women
    1999 2016 Trend 1
    Trend 2
    1999 2016 Trend 1
    Trend 2
    1999 2016 Trend 1
    Trend 2
    Year APC Year APC Year APC Year APC Year APC Year APC
    All sites 114.3 79.8 1999-2002 1.1 2002-2016 –2.7a) 176.6 115.5 1999-2002 1.3 2002-2016 –3.2a) 70.6 53.6 1999-2002 1.0 2002-2016 –2.2a)
    Lip, oral cavity, and pharynx 1.1 1.3 1999-2016 –1.8a) - - 2.0 2.2 1999-2016 –2.0a) - - 0.4 0.5 1999-2016 –2.5a) - -
    Esophagus 3.1 1.6 1999-2016 –4.3a) - - 6.8 3.2 1999-2016 –4.6a) - - 0.5 0.2 1999-2010 –6.4a) 2010-2016 –0.6
    Stomach 23.8 8.3 1999-2003 –3.2a) 2003-2016 –6.7a) 36.9 12.7 1999-2003 –2.5a) 2003-2016 –7.1a) 14.6 5.0 1999-2003 –4.4a) 2003-2016 –6.6a)
    Colon and rectum 7.7 8.2 1999-2004 5.8a) 2004-2016 –1.5a) 10.5 11.1 1999-2010 1.9a) 2010-2016 –3.8a) 6.0 5.9 1999-2004 5.1a) 2004-2016 –2.0a)
    Liver 20.4 11.7 1999-2002 1.0 2002-2016 –3.8a) 35.3 19.2 1999-2002 0.2 2002-2016 –3.9a) 8.3 5.2 1999-2002 2.9 2002-2016 –3.8a)
    Gallbladderb) 5.2 4.2 1999-2001 6.9 2001-2016 –2.6a) 6.8 5.3 1999-2001 5.5 2001-2016 –2.6a) 4.1 3.4 1999-2001 9.0 2001-2016 –2.6a)
    Pancreas 5.4 5.7 1999-2016 0.3a) - - 7.6 7.0 1999-2016 –0.4a) - - 3.9 4.6 1999-2016 0.9a) - -
    Larynx 1.6 0.3 1999-2016 –9.5a) - - 3.4 0.8 1999-2016 –9.1a) - - 0.4 0.0 1999-2010 –15.3a) 2010-2016 –8.0a)
    Lung 22.4 17.6 1999-2002 1.9 2002-2016 –2.1a) 41.5 31.2 1999-2001 4.3 2001-2016 –2.5a) 9.4 7.7 1999-2002 2.6 2002-2016 –1.7a)
    Breast 2.2 2.9 1999-2016 1.4a) - - 0.1 0.0 1999-2016 –4.3a) - - 4.2 5.5 1999-2016 1.6a) - -
    Cervix uteri 1.4 1.0 1999-2003 8.3a) 2003-2016 –5.1a) - - - - - - 2.6 1.8 1999-2003 7.7a) 2003-2016 –4.8a)
    Corpus uteri 0.1 0.4 1999-2002 52.0a) 2002-2016 3.4a) - - - - - - 0.1 0.7 1999-2002 51.7a) 2002-2016 3.7a)
    Ovary 0.9 1.3 1999-2001 10.2 2001-2016 0.4 - - - - - - 1.7 2.5 1999-2006 1.0a) - -
    Prostate 0.9 1.5 1999-2004 9.7a) 2004-2016 0.1 2.6 4.2 1999-2004 9.6a) 2002-2016 –0.4 - - - - - -
    Testis 0.0 0.0 1999-2016 –2.6 - - 0.1 0.0 1999-2016 –3.1a) - - - - - - - -
    Kidney 1.1 1.1 1999-2016 –0.1 - - 1.8 1.8 1999-2016 0.0 - - 0.5 0.5 1999-2016 –0.7 - -
    Bladder 1.3 1.3 1999-2011 10.0 2011-2016 –1.7a) 2.6 2.5 1999-2016 –1.6a) - - 0.5 0.5 1999-2001 10.3 2001-2016 –1.7a)
    Brain and CNS 1.9 1.7 1999-2002 4.2 2002-2016 –1.9a) 2.2 2.0 1999-2016 –1.5a) - - 1.6 1.4 1999-2016 –1.4a) - -
    Thyroid 0.4 0.3 1999-2003 7.4a) 2003-2016 –4.4a) 0.3 0.2 1999-2003 10.3 2003-2016 –4.5a) 0.5 0.4 1999-2004 4.5 2004-2016 –4.9a)
    Hodgkin lymphoma 0.0 0.1 1999-2004 22.5a) 2004-2016 –1.4 0.0 0.1 1999-2004 19.5a) 2004-2016 –2.3 0.0 0.0 1999-2003 43.6a) 2003-2016 0.0
    Non-Hodgkin lymphoma 2.1 1.9 1999-2016 –0.5a) - - 3.0 2.6 1999-2016 –0.8a) - - 1.4 1.4 1999-2016 –0.2 - -
    Multiple myeloma 0.6 1.0 1999-2003 12.7a) 2003-2016 0.9 0.8 1.2 1999-2003 11.0a) 2003-2016 0.8 0.4 0.9 1999-2005 9.8a) 2005-2016 0.3
    Leukemia 2.9 2.3 1999-2016 –1.7a) - - 3.5 2.8 1999-2016 –1.6a) - - 2.4 1.9 1999-2016 –1.9a)
    Other and ill-defined 7.8 4.3 1999-2016 –3.1a) - - 9.0 5.3 1999-2008 –0.3 2009-2016 –5.7a) 7.0 3.5 1999-2005 –7.0a) 2005-2016 –2.1a)
    Rank Age (yr)
    0-14 15-34 35-64 ≥ 65
    Men
     1 Leukemia (5.2) Thyroid (13.7) Stomach (85.6) Lung (435.1)
     2 Non-Hodgkin lymphoma (2.9) Leukemia (3.8) Colon and rectum (65.1) Stomach (353.1)
     3 Brain and CNS (2.3) Non-Hodgkin lymphoma (3.1) Liver (55.6) Prostate (313.4)
     4 Kidney (0.6) Colon and rectum (2.6) Lung (44.0) Colon and rectum (302.6)
     5 Liver (0.4) Testis (2.3) Thyroid (33.3) Liver (175.5)
    Women
     1 Leukemia (4.5) Thyroid (50.5) Breast (147.5) Colon and rectum (175.2)
     2 Brain and CNS (2.0) Breast (12.0) Thyroid (127.9) Stomach (137.2)
     3 Non-Hodgkin lymphoma (1.2) Cervix uteri (5.7) Colon and rectum (37.6) Lung (126.8)
     4 Ovary (0.5) Ovary (3.3) Stomach (37.6) Breast (89.5)
     5 Kidney (0.4) Leukemia (2.8) Lung (24.9) Liver (65.6)
    Site/Type Both sexes
    Men
    Women
    1993-1995 1996-2000 2001-2005 2006-2010 2011-2015 2012-2016 Changea) 1993-1995 1996-2000 2001-2005 2006-2010 2011-2015 2012-2016 Changea) 1993-1995 1996-2000 2001-2005 2006-2010 2011-2015 2012-2016 Changea)
    All sites 41.2 44.0 54.0 65.2 70.7 70.6 29.4 31.7 35.3 45.4 56.6 62.9 63.2 31.5 53.4 55.3 64.2 74.3 78.3 78.0 24.6
    Lip, oral cavity, and pharynx 41.1 46.7 54.3 60.8 64.9 65.4 24.3 35.8 41.1 49.5 56.7 61.3 62.1 26.3 58.1 63.8 67.9 71.8 74.2 73.9 15.8
    Esophagus 12.7 15.2 21.4 29.7 36.4 37.4 24.7 11.8 14.3 20.6 29.1 36.1 37.2 25.4 23.7 24.2 29.8 36.9 39.4 39.6 15.9
    Stomach 42.8 46.6 57.8 68.1 75.7 76.0 33.2 43.0 46.9 58.5 68.8 76.6 76.9 33.9 42.6 46.0 56.5 66.8 73.8 73.9 31.3
    Colon and rectum 54.8 58.0 66.7 73.6 76.2 75.9 21.1 55.3 59.0 68.6 75.5 77.9 77.8 22.5 54.2 56.8 64.3 70.8 73.6 73.2 19.0
    Liver 10.7 13.2 20.4 28.1 34.0 34.6 23.9 9.9 12.9 20.3 28.1 34.5 35.2 25.3 13.6 14.2 20.9 28.2 32.6 32.7 19.1
    Gallbladderb) 17.3 19.7 23.0 26.7 28.8 29.0 11.7 16.6 20.3 23.4 27.6 29.5 29.7 13.1 18.0 19.1 22.6 25.8 28.0 28.3 10.3
    Pancreas 9.4 7.6 8.4 8.4 10.7 11.4 2.0 8.8 7.3 8.4 8.2 10.3 11.2 2.4 10.1 8.1 8.4 8.7 11.2 11.7 1.6
    Larynx 59.7 62.3 66.2 72.8 75.2 75.7 16.0 60.2 62.8 66.8 73.1 75.7 76.3 16.1 55.4 57.8 58.5 67.7 67.9 65.8 10.4
    Lung 11.3 12.7 16.5 20.1 27.1 28.2 16.9 10.4 11.6 15.2 17.9 23.0 23.7 13.3 14.2 16.2 20.1 25.8 36.5 38.6 24.4
    Breast 77.9 83.2 88.6 91.1 92.5 92.7 14.8 75.1 85.6 87.2 89.5 86.3 89.3 14.2 78.0 83.2 88.6 91.1 92.6 92.7 14.7
    Cervix uteri 77.5 80.0 81.4 80.6 80.1 79.8 2.3 - - - - - - - 77.5 80.0 81.4 80.6 80.1 79.8 2.3
    Corpus uteri 81.5 81.8 84.7 86.4 87.8 87.5 6.0 - - - - - - - 81.5 81.8 84.7 86.4 87.8 87.5 6.0
    Ovary 58.7 58.9 61.6 61.1 63.9 64.0 5.3 - - - - - - - 58.7 58.9 61.6 61.1 63.9 64.0 5.3
    Prostate 55.9 67.2 80.4 91.1 94.0 93.9 38.0 55.9 67.2 80.4 91.1 94.0 93.9 38.0 - - - - - - -
    Testis 85.4 90.4 90.7 93.1 95.3 95.2 9.8 85.4 90.4 90.7 93.1 95.3 95.2 9.8 - - - - - - -
    Kidney 62.0 66.1 73.5 78.3 82.3 82.7 20.7 60.8 64.4 72.9 78.2 81.8 82.5 21.7 64.5 69.7 74.8 78.7 83.3 83.1 18.6
    Bladder 69.1 73.1 75.7 76.6 76.0 76.0 6.9 70.0 74.8 77.4 78.6 77.9 78.0 8.0 65.5 66.3 68.8 68.6 68.1 68.1 2.6
    Brain and CNS 38.5 39.0 41.0 42.8 41.1 41.4 2.9 37.2 37.5 40.2 41.3 39.4 39.3 2.1 40.2 40.7 41.8 44.4 43.1 43.9 3.7
    Thyroid 94.2 94.9 98.3 99.9 100.2 100.2 6.0 87.2 89.5 95.9 100.0 100.6 100.5 13.3 95.4 95.9 98.7 99.9 100.1 100.1 4.7
    Hodgkin lymphoma 68.0 71.2 76.6 80.9 82.3 83.0 15.0 67.6 68.1 74.6 80.7 82.2 81.9 14.3 68.6 77.4 80.7 81.4 82.5 85.0 16.4
    Non-Hodgkin lymphoma 46.6 50.8 55.9 59.3 62.7 63.1 16.5 45.3 48.9 54.9 59.0 62.7 63.2 17.9 48.7 53.5 57.4 59.6 62.8 63.0 14.3
    Multiple myeloma 22.1 19.8 29.6 34.9 41.1 41.9 19.8 21.1 17.8 29.7 35.0 40.3 40.3 19.2 23.3 22.1 29.4 34.8 41.9 43.6 20.3
    Leukemia 26.5 33.3 41.9 47.6 51.5 51.9 25.4 26.2 32.3 41.8 46.9 51.8 52.5 26.3 26.8 34.6 42.2 48.6 51.1 51.1 24.3
    Other and ill-defined 42.1 45.9 57.6 67.2 72.4 73.3 31.2 37.4 42.4 53.8 63.4 69.1 70.1 32.7 47.4 50.0 61.7 71.1 75.7 76.4 29.0
    Site/Type Crude prevalence rate per 100,000a)
    Age-standardized prevalence rate per 100,000b)
    Both sexes Men Women Both sexes Men Women
    All sites 3,404.1 2,993.2 3,814.1 2,046.2 1,896.1 2,281.5
    Lip, oral cavity, and pharynx 46.2 62.1 30.5 28.2 39.7 18.2
    Esophagus 19.1 34.4 3.9 10.5 20.9 1.9
    Stomach 535.5 709.9 361.4 297.8 433.6 185.7
    Colon and rectum 462.6 551.8 373.6 254.8 338.9 186.9
    Liver 126.9 190.6 63.3 74.7 119.1 34.6
    Gallbladderc) 41.1 42.2 40.0 21.8 25.6 18.9
    Pancreas 20.7 21.6 19.9 11.9 13.5 10.6
    Larynx 20.6 38.8 2.4 11.2 23.6 1.2
    Lung 149.8 185.8 113.8 82.7 113.6 58.9
    Breast 387.4 2.9 771.0 239.0 1.8 470.0
    Cervix uteri 103.2 - 206.2 62.6 - 122.3
    Corpus uteri 45.3 - 90.4 28.0 - 55.1
    Ovary 38.2 - 76.3 25.5 - 50.6
    Prostate 151.9 304.1 - 76.1 180.5 -
    Testis 6.3 12.6 - 5.7 11.1 -
    Kidney 76.0 102.5 49.5 46.3 65.8 29.0
    Bladder 65.6 107.1 24.2 34.4 65.2 10.9
    Brain and CNS 21.7 22.5 21.0 18.3 19.5 17.1
    Thyroid 743.3 255.9 1,229.7 487.5 171.0 801.9
    Hodgkin lymphoma 5.5 6.9 4.1 4.5 5.5 3.5
    Non-Hodgkin lymphoma 58.9 67.1 50.7 40.8 49.1 33.1
    Multiple myeloma 11.3 11.9 10.7 6.4 7.3 5.7
    Leukemia 40.6 45.3 36.0 37.4 41.8 33.0
    Other and ill-defined 226.4 217.1 235.6 139.9 149.0 132.6
    Table 1. Cancer incidence, deaths, and prevalence by sex in Korea, 2016

    CNS, central nervous system.

    Limited-duration prevalent cases on January 1, 2016. These are patients who were diagnosed between January 1, 1999 and December 31, 2016 and who were alive on January 1, 2017. Multiple primary cancer cases were counted multiple times,

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 2. Crude and age-standardized cancer incidence rates by sex in Korea, 2016

    CNS, central nervous system.

    Age-adjusted using the Segi’s world standard population,

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 3. The top 10 leading causes of death in Korea, 2016

    Source: Mortality Data, 2016, Statistics Korea [1].

    Age-adjusted using the Segi’s world standard population.

    Table 4. Crude and age-standardized cancer mortality rates by sex in Korea, 2016

    CNS, central nervous system.

    Age-adjusted using the world standard population,

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 5. Trends in cancer incidence rates from 1999 to 2016 in Korea

    APC was calculated using age-standardized incidence data based on the Segi’s world standard population. APC, annual percentage change; CNS, central nervous system.

    Significantly different from zero (p < 0.05),

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 6. Trends in cancer mortality rates from 1999 to 2016 in Korea

    APC was calculated using age-standardized incidence data based on the Segi’s world standard population. APC, annual percentage change; CNS, central nervous system.

    Significantly different from zero (p < 0.05),

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 7. The five common sites of cancer incidence by age group and sex in Korea, 2016

    CNS, central nervous system.

    Table 8. Trends in the 5-year relative survival rates (%) by year of diagnosis from 1993 to 2016 in Korea

    CNS, central nervous system.

    Percentage change in 5-year relative survival from 1993 to 1995 and 2012 to 2016,

    Includes the gallbladder and other/unspecified parts of the biliary tract.

    Table 9. Crude and age-standardized rates of cancer prevalence by sex on January 1, 2017 in Korea

    CNS, central nervous system.

    Crude prevalence rate: number of prevalent cases divided by the corresponding person-years of observation. Prevalent cases were defined as patients who were diagnosed between January 1, 1999 and December 31, 2016 and who were alive on January 1, 2017. Multiple primary cancer cases were counted multiple times,

    Age-adjusted using the Segi’s world standard population,

    Includes the gallbladder and other/unspecified parts of the biliary tract.


    Cancer Res Treat : Cancer Research and Treatment
    Close layer
    TOP